Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,A1BG,Alpha-1B-glycoprotein,43788,3214,1.69 [1.38-2.06],3.817726282648291e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABCA2,ATP-binding cassette sub-family A member 2,42287,3106,1.47 [1.35-1.60],6.683776172386356e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABL1,Tyrosine-protein kinase ABL1,50008,3649,1.18 [1.13-1.23],3.3213183213450324e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABRAXAS2,BRISC complex subunit Abraxas 2,42287,3106,1.10 [1.05-1.16],0.0001783002560203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",49060,3565,1.36 [1.32-1.40],2.945603627831283e-79
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAN,Aggrecan core protein,49760,3628,0.48 [0.43-0.53],1.7745318586203765e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE,Angiotensin-converting enzyme,43751,3210,1.71 [1.51-1.94],1.27081375869356e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE2,Angiotensin-converting enzyme 2,49323,3609,1.80 [1.72-1.88],4.3001009974138914e-160
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACHE,Acetylcholinesterase,42761,3137,1.29 [1.17-1.42],5.339373127837519e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACOT13,Acyl-coenzyme A thioesterase 13,43539,3194,1.05 [1.02-1.08],0.000864717836003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,50238,3669,1.10 [1.04-1.16],0.0008676567303775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,42452,3109,0.90 [0.84-0.97],0.0083652673706219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP5,Tartrate-resistant acid phosphatase type 5,50455,3692,2.12 [1.97-2.27],8.116128721748055e-98
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRBP,Acrosin-binding protein,43518,3190,1.13 [1.04-1.22],0.0045626675175858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRV1,Acrosomal protein SP-10,42452,3109,1.06 [1.02-1.10],0.0070046991673399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACVRL1,Serine/threonine-protein kinase receptor R3,49774,3640,1.33 [1.19-1.49],8.255173067714095e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY1,Aminoacylase-1,50238,3669,1.95 [1.88-2.03],2.6430030902391057e-237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,42287,3106,1.62 [1.54-1.71],9.93062037775396e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACYP1,Acylphosphatase-1,42600,3127,1.07 [1.02-1.13],0.0068794003607407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA,Adenosine deaminase,50792,3709,1.30 [1.21-1.41],1.1038788907746833e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA2,Adenosine deaminase 2,49951,3644,2.05 [1.93-2.19],3.829078197695784e-114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,42452,3109,1.47 [1.35-1.60],4.52323203222926e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,49323,3609,1.33 [1.21-1.47],2.441118139033232e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,50605,3694,1.52 [1.38-1.68],2.647868303893569e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,43539,3194,1.62 [1.46-1.79],3.1345141914061264e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,42452,3109,1.23 [1.11-1.37],0.0001015420294859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,50857,3718,2.09 [1.85-2.36],1.2600992962108568e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,50008,3649,1.34 [1.25-1.44],2.2217692683137787e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,42452,3109,1.23 [1.12-1.35],1.2623882906995132e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,50396,3675,0.83 [0.78-0.88],1.0311212847294704e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL2,ADAMTS-like protein 2,43726,3217,3.48 [3.24-3.74],3.0888953095212495e-251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL5,ADAMTS-like protein 5,43722,3201,0.81 [0.74-0.88],8.831959811213539e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRB3,Adhesion G protein-coupled receptor B3,49774,3640,1.33 [1.22-1.45],1.3824478148790969e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRD1,Adhesion G-protein coupled receptor D1,42761,3137,1.89 [1.74-2.04],4.020317814291196e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE1,Adhesion G protein-coupled receptor E1,43539,3194,1.22 [1.15-1.29],3.586553442888961e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE2,Adhesion G protein-coupled receptor E2,50453,3677,1.90 [1.73-2.10],5.11329375829735e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE5,Adhesion G protein-coupled receptor E5,50610,3703,1.92 [1.77-2.08],8.449942835004928e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRF5,Adhesion G protein-coupled receptor F5,43722,3201,1.30 [1.15-1.47],1.976572291753595e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG1,Adhesion G-protein coupled receptor G1,50008,3649,1.53 [1.49-1.57],1.2690889652923281e-213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG2,Adhesion G-protein coupled receptor G2,50238,3669,0.49 [0.46-0.53],1.1766192529914087e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH1B,All-trans-retinol dehydrogenase,42761,3137,1.42 [1.37-1.47],2.457938421680157e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,49323,3609,1.53 [1.48-1.58],1.6616710930258634e-132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADIPOQ,Adiponectin,43788,3214,0.53 [0.50-0.55],3.491331792670013e-150
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADM,Pro-adrenomedullin,50668,3699,1.75 [1.56-1.96],4.253745514372336e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFM,Afamin,43788,3214,4.77 [4.05-5.62],4.8938710209917245e-78
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFP,Alpha-fetoprotein,49693,3633,0.94 [0.90-0.98],0.0087020901030722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGER,Advanced glycosylation end product-specific receptor,50121,3654,0.87 [0.81-0.93],7.17754359242814e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR2,Anterior gradient protein 2 homolog,48685,3548,1.18 [1.15-1.21],4.725056446482542e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR3,Anterior gradient protein 3,48976,3558,1.37 [1.31-1.44],8.466982227877465e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRN,Agrin,50453,3677,1.94 [1.81-2.08],1.899556722039407e-78
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRP,Agouti-related protein,50792,3709,1.30 [1.23-1.38],1.5407943184104726e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGXT,Serine--pyruvate aminotransferase,50238,3669,1.45 [1.40-1.50],1.8362728125109227e-102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHCY,Adenosylhomocysteinase,50238,3669,1.09 [1.04-1.13],0.0001440272109128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSG,Alpha-2-HS-glycoprotein,43751,3210,1.78 [1.57-2.01],1.5229354450308932e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSP,Alpha-hemoglobin-stabilizing protein,50168,3674,1.07 [1.04-1.11],2.2667433292942207e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",49925,3644,1.18 [1.15-1.21],9.016858005144123e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AK2,"Adenylate kinase 2, mitochondrial",43613,3190,1.05 [1.01-1.08],0.0063453907218592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKAP12,A-kinase anchor protein 12,42761,3137,0.56 [0.47-0.67],9.318887303435943e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B1,Aldo-keto reductase family 1 member B1,49060,3565,1.06 [1.01-1.10],0.0071504137142427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B10,Aldo-keto reductase family 1 member B10,42513,3125,1.37 [1.32-1.43],1.854800291994264e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1C4,Aldo-keto reductase family 1 member C4,49323,3609,1.20 [1.14-1.25],1.7334136864397606e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,42452,3109,1.41 [1.35-1.46],6.012831968741001e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKT1S1,Proline-rich AKT1 substrate 1,49082,3568,1.11 [1.06-1.16],5.907621403148462e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALCAM,CD166 antigen,50857,3718,2.50 [2.18-2.87],4.0240235374971394e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH1A1,Retinal dehydrogenase 1,50252,3681,1.58 [1.51-1.65],2.580474224198717e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",43518,3190,1.12 [1.06-1.19],0.0001247724398899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",50085,3656,1.32 [1.28-1.37],3.190204957486364e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",43640,3195,1.25 [1.17-1.33],9.61342731302962e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPI,Intestinal-type alkaline phosphatase,42452,3109,1.08 [1.05-1.11],1.580595907802673e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPP,"Alkaline phosphatase, placental type",50008,3649,1.11 [1.08-1.14],5.442697048261623e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBN,Ameloblastin,49283,3574,0.84 [0.75-0.94],0.0025173457007398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBP,Protein AMBP,50596,3696,2.43 [2.11-2.79],8.99319891813667e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMFR,E3 ubiquitin-protein ligase AMFR,49082,3568,1.12 [1.07-1.17],1.167068677964024e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO2,Amphoterin-induced protein 2,50008,3649,2.05 [1.81-2.32],5.671216304108392e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMN,Protein amnionless,49283,3574,1.15 [1.08-1.22],6.550051164135064e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOT,Angiomotin,42761,3137,1.64 [1.51-1.78],4.463449686873324e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMPD3,AMP deaminase 3,43613,3190,1.08 [1.03-1.13],0.000683589623682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,40977,3001,0.78 [0.72-0.84],3.160571528740248e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2A,Pancreatic alpha-amylase,48298,3520,0.76 [0.71-0.81],3.461913399319426e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2B,Alpha-amylase 2B,46816,3409,0.74 [0.70-0.79],5.1158539466640284e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANG,Angiogenin,50115,3665,1.36 [1.25-1.47],4.755546631181785e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT1,Angiopoietin-1,50053,3650,1.07 [1.04-1.11],7.125212023888694e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT2,Angiopoietin-2,50668,3699,2.01 [1.87-2.16],3.715379213534896e-80
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL1,Angiopoietin-related protein 1,49504,3605,1.28 [1.16-1.42],1.3679352446829445e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL2,Angiopoietin-related protein 2,50290,3667,1.87 [1.74-2.01],6.48855338690965e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL3,Angiopoietin-related protein 3,50281,3675,0.55 [0.50-0.59],3.383246630150265e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL4,Angiopoietin-related protein 4,50372,3673,1.44 [1.35-1.54],1.817455200976651e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL7,Angiopoietin-related protein 7,50668,3699,1.95 [1.82-2.09],1.8173652630582145e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,42452,3109,1.06 [1.01-1.10],0.0094133136017281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANPEP,Aminopeptidase N,50363,3671,1.50 [1.36-1.66],6.07334789861223e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA1,Annexin A1,42516,3121,1.14 [1.06-1.23],0.0003272749064795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA10,Annexin A10,49082,3568,1.14 [1.10-1.18],1.6294851377795986e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA11,Annexin A11,50089,3661,1.07 [1.02-1.11],0.0061359257078843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA2,Annexin A2,41906,3074,1.18 [1.13-1.24],7.284579792976198e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA3,Annexin A3,50605,3694,1.10 [1.05-1.14],1.3367458427265493e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA5,Annexin A5,48918,3556,1.21 [1.10-1.34],0.0001193767608949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC3,Membrane primary amine oxidase,50445,3682,2.51 [2.29-2.75],9.865329120024666e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP1G2,AP-1 complex subunit gamma-like 2,43518,3190,1.15 [1.10-1.20],2.784564447787371e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP3B1,AP-3 complex subunit beta-1,43539,3194,1.11 [1.06-1.16],3.597226728193675e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP3S2,AP-3 complex subunit sigma-2,43613,3190,1.15 [1.07-1.22],6.975628895716809e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,50008,3649,1.30 [1.23-1.38],1.1168800517300022e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,50512,3690,1.21 [1.16-1.27],2.0552376675654024e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APLP1,Amyloid-like protein 1,50238,3669,0.77 [0.73-0.82],1.6816446100724309e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA1,Apolipoprotein A-I,43788,3214,0.39 [0.33-0.44],4.320384994264224e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA2,Apolipoprotein A-II,43751,3210,0.86 [0.80-0.92],5.906943557018123e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA4,Apolipoprotein A-IV,43788,3214,1.63 [1.51-1.76],2.508583100822969e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOBR,Apolipoprotein B receptor,42553,3118,0.85 [0.78-0.92],4.2462672912057294e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOC1,Apolipoprotein C-I,43706,3207,0.44 [0.40-0.48],7.201584219646051e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOD,Apolipoprotein D,41821,3083,0.34 [0.31-0.38],4.369867801759006e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOE,Apolipoprotein E,43788,3214,0.90 [0.85-0.95],0.0001587274332883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOF,Apolipoprotein F,43751,3210,0.49 [0.46-0.52],8.362417449643727e-110
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOH,Beta-2-glycoprotein 1,50252,3681,1.18 [1.09-1.27],3.4027341845721656e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOL1,Apolipoprotein L1,43751,3210,0.88 [0.83-0.93],1.9454574357394795e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOM,Apolipoprotein M,50363,3678,0.34 [0.31-0.38],6.1208109381043615e-105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APP,Amyloid-beta precursor protein,50176,3677,1.09 [1.05-1.14],6.90997672124474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APRT,Adenine phosphoribosyltransferase,49777,3644,1.12 [1.05-1.19],0.0002980679015127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARAF,Serine/threonine-protein kinase A-Raf,42925,3150,1.07 [1.02-1.12],0.0068952531710495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AREG,Amphiregulin,50008,3649,1.86 [1.77-1.97],1.495998201504241e-112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARF6,ADP-ribosylation factor 6,43539,3194,1.08 [1.05-1.12],6.994079211915466e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP1,Rho GTPase-activating protein 1,49060,3565,0.90 [0.85-0.96],0.0019176499057784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,43613,3190,1.11 [1.07-1.16],2.876526363879668e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,43640,3195,1.06 [1.02-1.10],0.0019826440695969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,50168,3665,1.06 [1.03-1.09],0.0001215210220435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSA,Arylsulfatase A,50252,3681,1.42 [1.34-1.51],2.1757408397944685e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSB,Arylsulfatase B,50008,3649,1.22 [1.16-1.28],2.2439126660935803e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ART3,Ecto-ADP-ribosyltransferase 3,50445,3682,0.73 [0.68-0.80],9.967909079569821e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH1,Acid ceramidase,43317,3193,1.33 [1.25-1.41],1.2213541594884195e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH2,Neutral ceramidase,49859,3646,1.70 [1.60-1.81],3.2733286915056195e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR1,Asialoglycoprotein receptor 1,49859,3646,3.04 [2.81-3.29],7.876751533790665e-169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR2,Asialoglycoprotein receptor 2,43751,3210,1.30 [1.15-1.47],3.271188868402236e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASPN,Asporin,43722,3201,1.22 [1.09-1.37],0.0005580671163218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASPSCR1,Tether containing UBX domain for GLUT4,43640,3195,1.10 [1.04-1.15],0.0003223065022841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASS1,Argininosuccinate synthase,42287,3106,1.36 [1.31-1.42],1.7432472504849896e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATG16L1,Autophagy-related protein 16-1,43539,3194,1.12 [1.07-1.16],4.8526667643881126e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATOX1,Copper transport protein ATOX1,50396,3675,1.12 [1.07-1.17],1.1964273848738317e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP5IF1,"ATPase inhibitor, mitochondrial",50453,3677,1.05 [1.02-1.07],0.0007465731765284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6AP2,Renin receptor,49060,3565,1.18 [1.11-1.26],9.958634874729062e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1G1,V-type proton ATPase subunit G 1,42553,3118,1.10 [1.05-1.15],0.000142082019068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRAID,All-trans retinoic acid-induced differentiation factor,43539,3194,1.24 [1.13-1.37],1.5029223088146222e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRN,"Attractin, Isoform 2",43788,3214,4.12 [3.43-4.96],6.919542642941451e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN2L,Ataxin-2-like protein,43640,3195,1.16 [1.09-1.23],8.801758420261058e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN3,Ataxin-3,43613,3190,1.08 [1.02-1.14],0.0053993870764083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXIN1,Axin-1,50168,3665,1.07 [1.04-1.11],9.739862354995048e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXL,Tyrosine-protein kinase receptor UFO,50445,3682,1.34 [1.20-1.48],4.2262355144707204e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AZI2,5-azacytidine-induced protein 2,43640,3195,1.16 [1.10-1.23],5.386033504775151e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AZU1,Azurocidin,48710,3574,1.08 [1.05-1.12],1.104975877839758e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B2M,Beta-2-microglobulin,43788,3214,1.29 [1.20-1.40],1.0018727941690491e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",42553,3118,2.48 [2.26-2.72],7.7282829688449885e-81
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",50453,3677,1.73 [1.57-1.92],1.3462366434076794e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BACH1,Transcription regulator protein BACH1,50168,3665,1.10 [1.06-1.15],2.089335517034536e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG3,BAG family molecular chaperone regulator 3,49774,3640,0.89 [0.83-0.95],0.0008317402398863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG4,BAG family molecular chaperone regulator 4,42452,3109,1.19 [1.12-1.28],1.0733758123804937e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,49060,3565,1.58 [1.53-1.64],5.109270257719498e-127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,49060,3565,1.22 [1.11-1.34],6.437886108808414e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BANK1,B-cell scaffold protein with ankyrin repeats,50168,3665,1.07 [1.05-1.11],5.149608824013298e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAP18,Chromatin complexes subunit BAP18,43613,3190,1.19 [1.14-1.24],1.1015818593276321e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAX,Apoptosis regulator BAX,48999,3563,1.06 [1.02-1.09],0.0007494649245216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAM,Basal cell adhesion molecule,50252,3681,1.48 [1.33-1.66],9.070873900005892e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAN,Brevican core protein,49859,3646,0.49 [0.45-0.53],4.514845609435211e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",43722,3201,1.30 [1.17-1.45],1.272914686581979e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCHE,Cholinesterase,42933,3148,2.03 [1.78-2.31],1.2287018899582384e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L1,Bcl-2-like protein 1,43613,3190,1.05 [1.01-1.09],0.00497149871665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",50168,3665,1.17 [1.09-1.26],7.737821082734141e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L15,Bcl-2-like protein 15,42452,3109,1.20 [1.13-1.26],2.659061867662652e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCR,Breakpoint cluster region protein,50168,3665,1.07 [1.04-1.11],1.1713964191360198e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BDNF,Brain-derived neurotrophic factor,43726,3217,1.08 [1.03-1.12],0.0003413271430297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BECN1,Beclin-1,42553,3118,1.18 [1.12-1.25],1.734504657435558e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGLAP,Osteocalcin,43726,3217,0.87 [0.84-0.91],1.9901011199821774e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BID,BH3-interacting domain death agonist,50168,3665,1.12 [1.08-1.17],5.0677939291574174e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BIN2,Bridging integrator 2,50252,3681,1.06 [1.03-1.09],0.0005100614773383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLNK,B-cell linker protein,42452,3109,1.12 [1.03-1.21],0.007092547955553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP4,Bone morphogenetic protein 4,49774,3640,1.21 [1.14-1.29],3.37484763651302e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP6,Bone morphogenetic protein 6,49243,3605,1.29 [1.20-1.39],3.2245915428360894e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMPER,BMP-binding endothelial regulator protein,42761,3137,3.17 [2.87-3.49],6.057566530280858e-116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,42452,3109,1.24 [1.15-1.33],1.0404873553119223e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOC,Brother of CDO,49323,3609,1.24 [1.09-1.41],0.000876227384765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOLA1,BolA-like protein 1,42308,3098,1.12 [1.05-1.19],0.0004784996693705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFA2,BPI fold-containing family A member 2,41034,3017,0.94 [0.91-0.97],0.0001095819129388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB1,BPI fold-containing family B member 1,50132,3669,0.82 [0.79-0.86],6.03897891915734e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB2,BPI fold-containing family B member 2,43641,3199,1.37 [1.31-1.43],3.675357915584479e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRAP,BRCA1-associated protein,43139,3160,1.06 [1.03-1.10],0.0001595679123444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRDT,Bromodomain testis-specific protein,42287,3106,1.19 [1.08-1.30],0.0002368024836622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BSG,Basigin,50709,3703,1.28 [1.12-1.48],0.0005201282949053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,50687,3698,1.19 [1.11-1.28],1.3907042974224495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST2,Bone marrow stromal antigen 2,50687,3698,1.43 [1.37-1.50],1.731116171314065e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTD,Biotinidase,43788,3214,2.29 [1.94-2.71],2.329368975185849e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN2A1,Butyrophilin subfamily 2 member A1,50453,3677,1.65 [1.49-1.83],1.2361748356606468e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN3A2,Butyrophilin subfamily 3 member A2,50168,3665,1.27 [1.18-1.37],5.127621353795981e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C19orf12,Protein C19orf12,49082,3568,1.40 [1.36-1.45],1.2396195219450465e-93
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,50445,3682,1.93 [1.83-2.04],5.691220588457017e-118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,43640,3195,1.25 [1.13-1.37],4.982563515922556e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,42683,3132,0.84 [0.78-0.90],1.576848316115791e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1RL,Complement C1r subcomponent-like protein,43711,3207,2.01 [1.69-2.40],4.4013839576065335e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1S,Complement C1s subcomponent,43788,3214,1.29 [1.10-1.52],0.0016761396890569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2,Complement C2,50363,3678,3.86 [3.34-4.46],7.09885298938787e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2CD2L,Phospholipid transfer protein C2CD2L,48999,3560,1.10 [1.03-1.18],0.0036927966213763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C3,Complement C3,41530,3031,1.47 [1.38-1.56],1.6362452630011774e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C4BPB,C4b-binding protein beta chain,50396,3675,0.87 [0.81-0.94],0.0002373358499567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C5,Complement C5,43788,3214,1.62 [1.31-2.01],1.0015084647197365e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7,Complement component C7,42735,3137,2.55 [2.30-2.83],4.2397141098497955e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7orf50,Uncharacterized protein C7orf50,43613,3190,1.21 [1.07-1.37],0.0029820044325679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9,Complement component C9,43751,3210,0.77 [0.73-0.82],7.123798335576775e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA12,Carbonic anhydrase 12,50008,3649,1.49 [1.37-1.62],5.397729937059641e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA14,Carbonic anhydrase 14,50668,3699,0.46 [0.42-0.49],6.359522719856111e-81
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA2,Carbonic anhydrase 2,50084,3668,1.06 [1.02-1.10],0.0052554857603125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA4,Carbonic anhydrase 4,50857,3718,0.80 [0.71-0.90],0.0002185118891098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",49323,3609,1.26 [1.23-1.30],5.7462999548265836e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA6,Carbonic anhydrase 6,50099,3666,0.80 [0.76-0.84],2.804694873139736e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA9,Carbonic anhydrase 9,50668,3699,1.31 [1.24-1.39],1.1578349998708311e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,43640,3195,1.12 [1.08-1.17],2.237109759210028e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACYBP,Calcyclin-binding protein,42684,3133,1.08 [1.04-1.12],7.696997358219028e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB2,Calretinin,49082,3568,1.30 [1.21-1.40],1.9447079764823299e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCA,Calcitonin,49776,3638,1.27 [1.22-1.33],1.0860370703270713e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,50510,3684,1.04 [1.01-1.07],0.0052918618272132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,42553,3118,1.12 [1.07-1.17],4.635751045140013e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,49060,3565,1.11 [1.04-1.18],0.0023479488061174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,43640,3195,1.07 [1.04-1.11],7.283754528573231e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CANT1,Soluble calcium-activated nucleotidase 1,50086,3655,1.85 [1.61-2.13],1.653849442707465e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPG,Macrophage-capping protein,49871,3643,1.16 [1.11-1.22],1.4705349954023623e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASC3,Protein CASC3,42513,3125,1.14 [1.06-1.24],0.0008285821548105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP1,Caspase-1,49082,3568,1.08 [1.03-1.12],0.000544959389595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP10,Caspase-10,49082,3568,1.07 [1.03-1.12],0.0013371249998987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP2,Caspase-2,50168,3665,1.08 [1.04-1.13],0.0001636595859719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLIF,Cobalamin binding intrinsic factor,50163,3667,1.27 [1.23-1.32],4.730250563092104e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLN4,Cerebellin-4,50668,3699,1.46 [1.35-1.57],4.618490037093804e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBS,Cystathionine beta-synthase,42553,3118,1.54 [1.46-1.62],4.424741979999293e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,49859,3646,1.13 [1.08-1.17],2.829938309455224e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC134,Coiled-coil domain-containing protein 134,43518,3190,1.09 [1.02-1.17],0.0097027605400563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC80,Coiled-coil domain-containing protein 80,50238,3669,1.25 [1.16-1.36],3.31926439516385e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL11,Eotaxin,50792,3709,1.60 [1.48-1.73],2.8014912895122158e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL13,C-C motif chemokine 13,50710,3701,1.10 [1.06-1.15],3.994883009143965e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL15,C-C motif chemokine 15,50857,3718,1.78 [1.68-1.89],1.525865083291349e-81
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL16,C-C motif chemokine 16,50857,3718,1.47 [1.39-1.55],1.6415254621255053e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL17,C-C motif chemokine 17,50123,3656,1.06 [1.03-1.09],0.0003344360748656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL18,C-C motif chemokine 18,49555,3632,1.12 [1.08-1.16],1.3825535745641757e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL19,C-C motif chemokine 19,50687,3698,1.08 [1.06-1.10],2.6731989121684586e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL20,C-C motif chemokine 20,50792,3709,1.27 [1.24-1.31],1.4997873770661737e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL21,C-C motif chemokine 21,50453,3677,1.42 [1.35-1.50],2.2275909152666487e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL22,C-C motif chemokine 22,49723,3632,1.29 [1.22-1.36],2.317906114206891e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL24,C-C motif chemokine 24,50372,3673,1.05 [1.02-1.09],0.0031044712763018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL25,C-C motif chemokine 25,50792,3709,1.31 [1.23-1.39],3.867288646942916e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL28,C-C motif chemokine 28,50004,3650,1.10 [1.05-1.15],0.0001796325403316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL3,C-C motif chemokine 3,50168,3665,1.18 [1.14-1.21],3.8083487780889406e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL4,C-C motif chemokine 4,50288,3667,1.12 [1.07-1.16],2.2613531262778882e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL5,C-C motif chemokine 5,50445,3682,1.09 [1.06-1.12],2.313624912945344e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL7,C-C motif chemokine 7,50168,3665,1.28 [1.22-1.33],4.7849620868805194e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN1,CCN family member 1,49926,3645,1.19 [1.14-1.23],2.947007889847035e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN2,CCN family member 2,50204,3659,1.08 [1.03-1.14],0.0021344709356807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN3,CCN family member 3,50772,3704,1.21 [1.11-1.31],5.869799579135095e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN4,CCN family member 4,50668,3699,1.48 [1.39-1.58],9.31529544729347e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN5,CCN family member 5,50252,3681,1.22 [1.13-1.31],1.894086204705289e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCT5,T-complex protein 1 subunit epsilon,49060,3565,1.10 [1.03-1.17],0.0031303545546608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD101,Immunoglobulin superfamily member 2,43539,3194,1.44 [1.33-1.56],8.0554813450293015e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD109,CD109 antigen,50252,3681,1.61 [1.48-1.76],4.217514299083631e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD14,Monocyte differentiation antigen CD14,49223,3612,1.37 [1.27-1.46],7.961500599180209e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD160,CD160 antigen,50792,3709,1.15 [1.08-1.22],5.080062413708112e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,50445,3682,1.83 [1.72-1.94],1.8439916210404345e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164,Sialomucin core protein 24,50252,3681,1.44 [1.35-1.55],2.399418879924909e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD1C,T-cell surface glycoprotein CD1c,50396,3675,0.67 [0.60-0.75],1.2202020082560338e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2,T-cell surface antigen CD2,42287,3106,1.20 [1.11-1.29],2.7371594675906994e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200,OX-2 membrane glycoprotein,50168,3665,0.80 [0.71-0.89],5.433763918474106e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,50002,3650,1.24 [1.14-1.34],4.0457572376756853e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD207,C-type lectin domain family 4 member K,49143,3585,1.41 [1.31-1.53],4.6853605954972085e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD209,CD209 antigen,50368,3683,0.87 [0.81-0.94],0.0003711219614698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD22,B-cell receptor CD22,50792,3709,1.51 [1.41-1.60],5.596396472957573e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD226,CD226 antigen,42452,3109,1.14 [1.06-1.24],0.0009052975011684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD244,Natural killer cell receptor 2B4,50792,3709,1.69 [1.52-1.87],4.635025798381606e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD248,Endosialin,43726,3217,0.61 [0.56-0.66],1.247788949309434e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD27,CD27 antigen,50396,3675,1.52 [1.42-1.62],2.8662257519286847e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD274,Programmed cell death 1 ligand 1,49859,3646,1.52 [1.40-1.64],2.3775454635995864e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD276,CD276 antigen,50204,3657,1.65 [1.52-1.80],1.6064981917042368e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD28,T-cell-specific surface glycoprotein CD28,49060,3565,1.57 [1.47-1.69],1.3639778226646574e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2AP,CD2-associated protein,50238,3669,1.15 [1.10-1.21],2.062301227028265e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300A,CMRF35-like molecule 8,42761,3137,1.52 [1.36-1.70],7.119179098397024e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300C,CMRF35-like molecule 6,50687,3698,1.47 [1.36-1.59],1.6649236537045752e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300E,CMRF35-like molecule 2,50506,3687,1.37 [1.28-1.47],1.00724820547444e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LF,CMRF35-like molecule 1,50668,3699,1.10 [1.05-1.15],3.2828658102378146e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LG,CMRF35-like molecule 9,50252,3681,0.53 [0.49-0.58],1.214008542869433e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD302,CD302 antigen,50008,3649,1.51 [1.38-1.65],1.6212069363681141e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD33,Myeloid cell surface antigen CD33,50396,3675,1.08 [1.04-1.12],0.0001268418013796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD34,Hematopoietic progenitor cell antigen CD34,50528,3688,0.48 [0.43-0.54],5.471151067047285e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD36,Platelet glycoprotein 4,42452,3109,1.28 [1.20-1.38],6.715469099896416e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,50008,3649,1.52 [1.39-1.66],3.18462182373859e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD4,T-cell surface glycoprotein CD4,50087,3659,1.56 [1.46-1.67],1.3455362299803676e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD40,Tumor necrosis factor receptor superfamily member 5,50207,3663,1.25 [1.18-1.32],6.455402818882392e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD46,Membrane cofactor protein,49954,3651,1.35 [1.22-1.48],3.3478459810712143e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD48,CD48 antigen,50372,3673,1.74 [1.58-1.91],6.5926117790894635e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5,T-cell surface glycoprotein CD5,50596,3696,1.66 [1.56-1.77],3.0315657032203823e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD58,Lymphocyte function-associated antigen 3,50121,3650,0.77 [0.65-0.90],0.0013114393495063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD59,CD59 glycoprotein,48431,3537,1.48 [1.31-1.67],4.0163514693585007e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD6,T-cell differentiation antigen CD6,50709,3703,1.27 [1.21-1.35],3.495606794729558e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD63,CD63 antigen,49774,3640,1.32 [1.25-1.40],5.8192484868734656e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD69,Early activation antigen CD69,49991,3650,1.08 [1.04-1.11],1.755894303581811e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD7,T-cell antigen CD7,42370,3098,1.27 [1.18-1.37],9.717839313384955e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD72,B-cell differentiation antigen CD72,42761,3137,1.43 [1.32-1.54],4.573610979403349e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD74,HLA class II histocompatibility antigen gamma chain,50687,3698,1.78 [1.65-1.93],2.727843915640669e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,50792,3709,1.28 [1.20-1.36],7.89919485513924e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD80,T-lymphocyte activation antigen CD80,43722,3201,2.42 [2.24-2.62],1.6619998167790773e-104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD83,CD83 antigen,50168,3665,1.73 [1.60-1.88],7.756424056998297e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,50687,3698,1.42 [1.34-1.49],1.16114309296964e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD93,Complement component C1q receptor,48350,3553,0.82 [0.74-0.90],4.546262517062641e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDA,Cytidine deaminase,43637,3195,1.23 [1.15-1.31],3.442565983523778e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC26,Anaphase-promoting complex subunit CDC26,43457,3187,1.07 [1.02-1.12],0.0082799338705237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC27,Cell division cycle protein 27 homolog,49060,3565,1.13 [1.08-1.18],5.799466772307205e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,43539,3194,1.07 [1.03-1.10],0.0001257998274495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDCP1,CUB domain-containing protein 1,49859,3646,1.71 [1.63-1.79],1.0240279240896435e-114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH1,Cadherin-1,48566,3529,1.68 [1.60-1.77],1.7091107311451564e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH15,Cadherin-15,50604,3690,1.42 [1.37-1.47],7.57081418135533e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH17,Cadherin-17,50238,3669,1.38 [1.33-1.44],2.335413797510529e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH2,Cadherin-2,50238,3669,2.91 [2.70-3.13],1.150390193687852e-170
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH23,Cadherin-23,43613,3190,0.84 [0.73-0.96],0.0091838221640497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH6,Cadherin-6,50238,3669,1.35 [1.25-1.45],2.8941647917637368e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR1,Cadherin-related family member 1,49082,3568,1.15 [1.07-1.22],3.8995251928174735e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR2,Cadherin-related family member 2,50008,3649,1.64 [1.58-1.72],5.620594944607553e-113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR5,Cadherin-related family member 5,50238,3669,1.37 [1.27-1.48],5.223325912085897e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDK1,Cyclin-dependent kinase 1,42155,3087,1.21 [1.10-1.33],6.488832570977907e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,43640,3195,1.08 [1.02-1.14],0.0092283640662078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,50008,3649,1.11 [1.08-1.14],2.58161601700305e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,50288,3666,1.70 [1.53-1.90],4.238342546691974e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDSN,Corneodesmosin,50634,3691,0.82 [0.77-0.88],1.0162514128346168e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,50319,3668,1.97 [1.75-2.22],3.84940013374569e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,43539,3194,1.11 [1.07-1.16],8.851253337983665e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,42925,3150,1.21 [1.13-1.30],2.2038229263763087e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,50168,3665,1.07 [1.04-1.11],1.843100851888025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,48425,3526,1.22 [1.17-1.28],9.015102856798242e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,43726,3217,1.41 [1.31-1.51],1.5793131593902824e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,49323,3609,1.25 [1.18-1.32],3.595173262554456e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEBPA,CCAAT/enhancer-binding protein alpha,42452,3109,1.14 [1.05-1.25],0.002721656755694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEBPB,CCAAT/enhancer-binding protein beta,49323,3609,1.18 [1.09-1.26],1.2948377361459162e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEMIP2,Cell surface hyaluronidase,42452,3109,1.56 [1.46-1.66],9.743782556070657e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP170,Centrosomal protein of 170 kDa,42553,3118,1.07 [1.03-1.12],0.0011407263363566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP20,Centrosomal protein 20,49060,3565,1.14 [1.09-1.18],1.2727405714157256e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP43,Centrosomal protein 43,48934,3585,1.13 [1.08-1.18],1.9596501781400483e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP85,Centrosomal protein of 85 kDa,49060,3565,1.12 [1.07-1.17],7.437052733330357e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CERT,Ceramide transfer protein,49082,3568,1.07 [1.02-1.13],0.0038380001455601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES1,Liver carboxylesterase 1,50361,3679,1.50 [1.45-1.54],9.52273188436636e-166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES2,Cocaine esterase,50008,3649,1.48 [1.41-1.55],4.201266717564009e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES3,Carboxylesterase 3,50008,3649,1.20 [1.16-1.25],1.5150387754971385e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CETN2,Centrin-2,49082,3568,1.11 [1.06-1.16],3.3128208757725896e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CETN3,Centrin-3,43539,3194,1.07 [1.02-1.11],0.0031712526793271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFB,Complement factor B,42985,3148,2.38 [2.14-2.65],2.626844495421257e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFC1,Cryptic protein,49060,3565,1.29 [1.22-1.37],5.684543801642922e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFD,Complement factor D,43788,3214,0.76 [0.64-0.90],0.0018732359361964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFH,Complement factor H,41225,3013,3.64 [3.16-4.21],3.864537379710613e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR4,Complement factor H-related protein 4,43704,3209,0.85 [0.81-0.89],1.1694398104801318e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR5,Complement factor H-related protein 5,43180,3162,0.89 [0.82-0.96],0.0034296701640772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFI,Complement factor I,43788,3214,4.75 [4.02-5.60],7.435814816163407e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGA,Glycoprotein hormones alpha chain,50252,3681,1.08 [1.04-1.13],0.0003361950246563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGREF1,Cell growth regulator with EF hand domain protein 1,50238,3669,1.50 [1.40-1.60],3.2841714201576304e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAD,Chondroadherin,42761,3137,0.54 [0.50-0.58],1.6271938692190131e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",43613,3190,1.78 [1.67-1.90],4.816271541565735e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD6,MICOS complex subunit MIC25,43518,3190,1.55 [1.42-1.68],5.690981601945984e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGA,Chromogranin-A,43726,3217,1.15 [1.11-1.18],2.6055871981673407e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHI3L1,Chitinase-3-like protein 1,49143,3579,1.30 [1.26-1.34],8.360995354734386e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHL1,Neural cell adhesion molecule L1-like protein,50372,3679,0.66 [0.60-0.73],1.8561902174372048e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHMP6,Charged multivesicular body protein 6,43722,3201,1.15 [1.08-1.22],5.856139693395456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL2,Chordin-like protein 2,50238,3669,1.31 [1.24-1.38],1.1085499762117266e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIAPIN1,Anamorsin,50396,3675,1.10 [1.05-1.15],0.0001134711163275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CILP,Cartilage intermediate layer protein 1,43726,3217,1.73 [1.63-1.85],2.691175517954179e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIRBP,Cold-inducible RNA-binding protein,43539,3194,1.05 [1.01-1.09],0.0088639111132408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIT,Citron Rho-interacting kinase,42513,3125,1.12 [1.04-1.20],0.0028535500209669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKAP4,Cytoskeleton-associated protein 4,50545,3694,1.51 [1.37-1.67],8.688077472635054e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKB,Creatine kinase B-type,43726,3217,0.57 [0.54-0.60],4.918109521569021e-80
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",50040,3647,1.15 [1.09-1.20],8.192980789715451e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC12A,C-type lectin domain family 12 member A,42452,3109,1.42 [1.21-1.66],1.4626816337162714e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC14A,C-type lectin domain family 14 member A,50252,3681,1.14 [1.04-1.24],0.0056975042658936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC1B,C-type lectin domain family 1 member B,50687,3698,1.09 [1.05-1.12],6.830604596364857e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC3B,Tetranectin,42762,3132,0.39 [0.33-0.46],1.2266955829123008e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4A,C-type lectin domain family 4 member A,50168,3665,0.64 [0.59-0.69],1.425182268289125e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4D,C-type lectin domain family 4 member D,50168,3665,1.28 [1.22-1.34],8.00697194589501e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4G,C-type lectin domain family 4 member G,50168,3665,1.19 [1.09-1.30],6.971720224285943e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4M,C-type lectin domain family 4 member M,43650,3213,0.82 [0.76-0.88],1.2166751173193746e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC5A,C-type lectin domain family 5 member A,50073,3660,1.26 [1.14-1.38],2.2728207968062493e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC6A,C-type lectin domain family 6 member A,49060,3565,1.34 [1.26-1.42],1.4430189869859745e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC7A,C-type lectin domain family 7 member A,50792,3709,1.09 [1.03-1.15],0.0018253584525899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLGN,Calmegin,42513,3125,1.13 [1.05-1.21],0.0012385425721513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLIP2,CAP-Gly domain-containing linker protein 2,50168,3665,1.07 [1.04-1.09],1.278814467987208e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",49776,3638,1.08 [1.05-1.12],1.625361117628243e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLPS,Colipase,50168,3674,0.93 [0.89-0.97],0.0003161344044424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN1,Calsyntenin-1,49082,3568,1.09 [1.03-1.15],0.0027332852299966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN2,Calsyntenin-2,50792,3709,1.50 [1.41-1.60],1.9614186774249664e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN3,Calsyntenin-3,43613,3190,1.73 [1.56-1.91],1.575300908931642e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLUL1,Clusterin-like protein 1,50157,3662,0.68 [0.64-0.73],1.2766684977037882e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CMC1,COX assembly mitochondrial protein homolog,43722,3201,1.06 [1.02-1.10],0.0016293790891447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CMIP,C-Maf-inducing protein,43518,3190,1.07 [1.03-1.11],0.0010835687191309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNDP1,Beta-Ala-His dipeptidase,50445,3682,1.09 [1.02-1.16],0.0088317246121514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",42474,3110,1.12 [1.07-1.17],2.0245691513742179e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNPY4,Protein canopy homolog 4,50008,3649,1.08 [1.04-1.12],0.0001655086607747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNST,Consortin,50238,3669,1.07 [1.04-1.10],1.1362778096239716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN2,Contactin-2,50668,3699,1.31 [1.23-1.39],1.7499109969859807e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN3,Contactin-3,50252,3681,2.79 [2.54-3.06],3.5504531613867485e-102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN4,Contactin-4,50252,3681,1.80 [1.60-2.03],7.77320002629856e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN5,Contactin-5,50369,3673,0.76 [0.70-0.82],6.82032248215918e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTNAP2,Contactin-associated protein-like 2,50168,3665,1.22 [1.14-1.30],9.32992109232821e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COCH,Cochlin,43722,3201,1.20 [1.12-1.28],4.716085851563817e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL15A1,Collagen alpha-1(XV) chain,43726,3217,0.62 [0.55-0.70],9.19124937067364e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL18A1,Collagen alpha-1(XVIII) chain,50449,3685,1.94 [1.72-2.19],4.897906471473551e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL1A1,Collagen alpha-1(I) chain,50857,3718,0.65 [0.58-0.74],5.068099126615086e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL2A1,Collagen alpha-1(II) chain,42553,3118,1.09 [1.04-1.13],0.0001097092862878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL3A1,Collagen alpha-1(III) chain,43726,3217,2.26 [1.98-2.57],7.1160307171115135e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A1,Collagen alpha-1(IV) chain,50238,3669,1.25 [1.16-1.34],1.453772051958826e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL5A1,Collagen alpha-1(V) chain,42761,3137,1.70 [1.58-1.83],2.938858325384642e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL6A3,Collagen alpha-3(VI) chain,50857,3718,1.73 [1.60-1.87],5.3856536539150335e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL9A1,Collagen alpha-1(IX) chain,50168,3665,0.81 [0.76-0.87],1.7910135704638496e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COLEC12,Collectin-12,50204,3657,1.77 [1.59-1.97],4.217849402537403e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMMD1,COMM domain-containing protein 1,42553,3118,1.12 [1.06-1.18],9.50928260756088e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMP,Cartilage oligomeric matrix protein,49709,3628,0.80 [0.73-0.87],2.694229870849977e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMT,Catechol O-methyltransferase,48791,3577,1.07 [1.03-1.11],0.0001600908057504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CORO1A,Coronin-1A,49228,3604,1.07 [1.04-1.11],2.443303264101689e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",50008,3649,1.11 [1.06-1.15],1.1380411646469714e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX6B1,Cytochrome c oxidase subunit 6B1,43722,3201,1.22 [1.11-1.35],6.409505240872111e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA2,Carboxypeptidase A2,50519,3685,1.34 [1.28-1.40],6.386048698437916e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA4,Carboxypeptidase A4,41910,3061,0.83 [0.77-0.90],7.915359069031791e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPE,Carboxypeptidase E,50274,3661,0.75 [0.70-0.81],4.7952678221007085e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPM,Carboxypeptidase M,50439,3673,3.37 [3.13-3.62],1.8653739825878232e-238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,50687,3698,1.08 [1.04-1.13],0.0003570625341169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPQ,Carboxypeptidase Q,43645,3214,1.54 [1.41-1.69],1.4140572352117194e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPVL,Probable serine carboxypeptidase CPVL,50584,3693,1.30 [1.21-1.40],4.561005620707852e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM1,Probable carboxypeptidase X1,50396,3675,1.09 [1.04-1.13],6.763632908109662e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM2,Inactive carboxypeptidase-like protein X2,43722,3201,1.63 [1.45-1.84],1.6633314638574769e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR1,Complement receptor type 1,43584,3199,1.54 [1.40-1.68],8.371370625169912e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR2,Complement receptor type 2,50445,3682,1.44 [1.36-1.53],5.147218277661996e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,49060,3565,1.07 [1.03-1.10],0.0002668185692066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREG1,Protein CREG1,49586,3619,1.18 [1.10-1.27],8.368863121893692e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD1,Protein disulfide isomerase CRELD1,42761,3137,2.37 [2.17-2.59],8.2237618930317425e-81
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD2,Protein disulfide isomerase CRELD2,50372,3673,1.24 [1.18-1.31],4.9997687009644935e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRH,Corticoliberin,48979,3560,0.81 [0.78-0.84],2.4069209639275928e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHBP,Corticotropin-releasing factor-binding protein,50204,3657,2.79 [2.51-3.09],8.723949330152402e-84
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIM1,Cysteine-rich motor neuron 1 protein,50453,3677,1.26 [1.10-1.46],0.0012975230738617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIP2,Cysteine-rich protein 2,49859,3646,1.55 [1.45-1.65],1.47680452765461e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP2,Cysteine-rich secretory protein 2,50668,3699,0.85 [0.81-0.89],7.600670662597186e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP3,Cysteine-rich secretory protein 3,43341,3176,0.60 [0.53-0.68],4.2260164632039556e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRKL,Crk-like protein,50289,3666,1.05 [1.02-1.07],0.0018230062042644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRLF1,Cytokine receptor-like factor 1,50453,3677,1.67 [1.49-1.88],1.0042965777165053e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRNN,Cornulin,48802,3562,0.83 [0.80-0.87],2.311741481493986e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAC1,Cartilage acidic protein 1,50857,3718,0.58 [0.53-0.63],1.0365698575755287e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYM,Ketimine reductase mu-crystallin,42308,3098,1.07 [1.03-1.12],0.0014970121519696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1,Macrophage colony-stimulating factor 1,50453,3677,2.09 [1.89-2.31],5.878811660611567e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,43751,3210,1.75 [1.62-1.89],3.4240423035760167e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2,Granulocyte-macrophage colony-stimulating factor,42287,3106,1.32 [1.22-1.44],6.409590411492169e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,49859,3646,1.19 [1.14-1.25],5.72176596937526e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF3,Granulocyte colony-stimulating factor,49283,3574,1.13 [1.06-1.20],7.093440554799431e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF3R,Granulocyte colony-stimulating factor receptor,42452,3109,1.27 [1.16-1.40],6.501915498184729e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSNK2A1,Casein kinase II subunit alpha,43640,3195,0.86 [0.80-0.93],9.321120192061272e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSPG5,Chondroitin sulfate proteoglycan 5,42308,3098,0.90 [0.83-0.96],0.0035164696118862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST3,Cystatin-C,50364,3670,1.64 [1.49-1.81],4.773190712009118e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST6,Cystatin-M,48913,3565,0.83 [0.78-0.88],9.972309870105136e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST7,Cystatin-F,50288,3667,1.13 [1.10-1.16],6.315558146350793e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSTB,Cystatin-B,49543,3620,1.30 [1.21-1.39],2.6213745757916846e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTBS,Di-N-acetylchitobiase,43117,3155,2.56 [2.28-2.89],1.4206454605954948e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTF1,Cardiotrophin-1,49323,3609,1.05 [1.02-1.09],0.0031010256961541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTHRC1,Collagen triple helix repeat-containing protein 1,43726,3217,1.56 [1.39-1.74],7.19986044434846e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRC,Chymotrypsin-C,50208,3663,0.84 [0.80-0.88],1.3068124418326086e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRL,Chymotrypsin-like protease CTRL-1,43613,3190,0.86 [0.82-0.90],3.8011304804727647e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSB,Cathepsin B,50288,3670,0.74 [0.70-0.79],7.941188085998129e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSC,Dipeptidyl peptidase 1,50118,3654,1.34 [1.26-1.43],1.2920603329682535e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSD,Cathepsin D,46952,3435,2.07 [1.97-2.18],4.1926544767040187e-184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSE,Cathepsin E,42761,3137,1.41 [1.33-1.51],1.818314536275957e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSH,Pro-cathepsin H,49157,3604,1.11 [1.07-1.16],1.829526819359256e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSL,Cathepsin L1,50238,3669,1.81 [1.62-2.04],2.6870608904410805e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSO,Cathepsin O,50792,3709,2.95 [2.73-3.19],6.880662200810061e-161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSS,Cathepsin S,39484,2892,2.87 [2.49-3.31],1.390742907079153e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSZ,Cathepsin Z,50280,3668,2.16 [1.98-2.35],2.007808701037434e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,42513,3125,1.14 [1.06-1.24],0.0008986254045806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CWC15,Spliceosome-associated protein CWC15 homolog,43289,3176,1.13 [1.08-1.19],9.235007557969586e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CX3CL1,Fractalkine,49859,3646,0.77 [0.70-0.84],3.55965938373895e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXADR,Coxsackievirus and adenovirus receptor,50168,3665,1.22 [1.15-1.29],5.150383794753012e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL10,C-X-C motif chemokine 10,50453,3677,1.12 [1.07-1.16],1.5394765083966918e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL11,C-X-C motif chemokine 11,50687,3698,1.07 [1.04-1.11],4.929266638013684e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL12,Stromal cell-derived factor 1,49283,3574,0.87 [0.80-0.93],0.0001792728023573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL13,C-X-C motif chemokine 13,50687,3698,1.18 [1.14-1.22],8.06281095301433e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL16,C-X-C motif chemokine 16,50773,3714,1.69 [1.50-1.90],1.2664342065466897e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL17,C-X-C motif chemokine 17,50792,3709,1.38 [1.30-1.47],3.231549427169635e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL5,C-X-C motif chemokine 5,50074,3660,1.07 [1.04-1.09],3.915374135460432e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL6,C-X-C motif chemokine 6,50792,3709,1.18 [1.14-1.23],6.896007251379452e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL8,Interleukin-8,49861,3637,1.18 [1.14-1.23],6.657853472511036e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL9,C-X-C motif chemokine 9,50453,3677,1.11 [1.06-1.16],2.643980839863346e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYB5A,Cytochrome b5,42155,3087,1.06 [1.02-1.11],0.0052184079931056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYB5R2,NADH-cytochrome b5 reductase 2,43055,3163,1.09 [1.03-1.16],0.0032038248907275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYTL1,Cytokine-like protein 1,43726,3217,0.55 [0.48-0.64],6.111206619886184e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAAM1,Disheveled-associated activator of morphogenesis 1,42761,3137,1.10 [1.06-1.15],3.0054809714023567e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAB2,Disabled homolog 2,50668,3699,1.05 [1.03-1.08],0.000124630962414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAG1,Dystroglycan,50453,3677,1.53 [1.44-1.62],1.302613882362588e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAPK2,Death-associated protein kinase 2,42452,3109,1.12 [1.06-1.19],8.402656933762163e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBI,Acyl-CoA-binding protein,50019,3663,1.10 [1.06-1.14],7.165364854772569e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBNL,Drebrin-like protein,50453,3677,1.05 [1.02-1.08],0.0026490786066019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",50396,3675,1.75 [1.62-1.90],7.09455105587807e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN1,Dynactin subunit 1,50668,3699,1.11 [1.06-1.16],5.491534861141815e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN6,Dynactin subunit 6,49082,3568,1.06 [1.02-1.10],0.0033448208862374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCXR,L-xylulose reductase,50396,3675,1.56 [1.49-1.64],4.673058969468188e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",50008,3649,1.56 [1.47-1.65],1.2066581891576929e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDC,Aromatic-L-amino-acid decarboxylase,50163,3667,1.13 [1.06-1.20],5.2876804329319335e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDHD2,Phospholipase DDHD2,43640,3195,1.12 [1.07-1.18],1.0792457407327954e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDR1,Epithelial discoidin domain-containing receptor 1,50687,3698,2.02 [1.80-2.27],3.0463923091853757e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDT,D-dopachrome decarboxylase,43726,3217,1.37 [1.27-1.47],2.8906706895558614e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX58,Antiviral innate immune response receptor RIG-I,49060,3565,1.09 [1.03-1.14],0.0008627940684318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",50168,3665,1.08 [1.05-1.12],4.128171502506293e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFA1_DEFA1B,Neutrophil defensin 1,49233,3600,1.10 [1.04-1.16],0.0004446681326262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB103A_DEFB103B,Beta-defensin 103,42128,3088,1.31 [1.23-1.40],6.72700137425881e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB4A_DEFB4B,Beta-defensin 4A,49525,3624,1.09 [1.07-1.11],2.404310518043812e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DFFA,DNA fragmentation factor subunit alpha,50792,3709,1.10 [1.05-1.14],2.229885729372664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DGKA,Diacylglycerol kinase alpha,42452,3109,1.17 [1.10-1.25],3.114166260426763e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHPS,Deoxyhypusine synthase,43518,3190,1.29 [1.21-1.37],2.283410011410899e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK2B,Divergent protein kinase domain 2B,42761,3137,0.66 [0.59-0.75],1.9254018048757697e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK1,Dickkopf-related protein 1,50687,3698,1.16 [1.11-1.22],1.4451984337069882e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK4,Dickkopf-related protein 4,49775,3640,1.50 [1.42-1.59],2.7490605213103895e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLK1,Protein delta homolog 1,50857,3718,1.20 [1.14-1.26],5.335672234862822e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL1,Delta-like protein 1,50396,3675,1.58 [1.44-1.74],6.334201536805322e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMD,Dystrophin,42553,3118,1.19 [1.12-1.27],2.1237544051078232e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMP1,Dentin matrix acidic phosphoprotein 1,42553,3118,0.63 [0.60-0.65],1.3714600500611233e-96
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA1,DnaJ homolog subfamily A member 1,42155,3087,0.89 [0.82-0.97],0.0048049957276466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA2,DnaJ homolog subfamily A member 2,50628,3700,1.11 [1.07-1.15],6.2695319631428814e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB1,DnaJ homolog subfamily B member 1,50008,3649,1.10 [1.06-1.13],8.496958297418297e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB14,DnaJ homolog subfamily B member 14,43539,3194,1.11 [1.06-1.17],4.819748384246357e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB6,DnaJ homolog subfamily B member 6,42363,3108,1.08 [1.04-1.13],0.0001947032202457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,42553,3118,1.11 [1.07-1.16],1.3861208761238102e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,50127,3656,0.82 [0.73-0.92],0.0004436269580621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNM3,Dynamin-3,43640,3195,1.17 [1.11-1.24],3.2200948218087216e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNMBP,Dynamin-binding protein,49859,3646,1.14 [1.09-1.20],1.9172072890110804e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNPEP,Aspartyl aminopeptidase,43613,3190,1.26 [1.19-1.34],1.5595945490148212e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,50370,3670,1.11 [1.05-1.18],0.000156967814529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOK2,Docking protein 2,50238,3669,1.05 [1.03-1.08],1.4573077905016543e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP10,Inactive dipeptidyl peptidase 10,50168,3665,1.57 [1.46-1.68],9.26085862781628e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP4,Dipeptidyl peptidase 4,49308,3610,1.23 [1.12-1.36],4.224164432010536e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,50008,3649,1.92 [1.77-2.09],7.827101410186531e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP7,Dipeptidyl peptidase 2,49830,3639,1.26 [1.20-1.32],3.244356068586136e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPT,Dermatopontin,50857,3718,1.29 [1.15-1.46],1.4059072278732557e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPY30,Protein dpy-30 homolog,50512,3690,1.37 [1.32-1.43],1.7213343494184996e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DRG2,Developmentally-regulated GTP-binding protein 2,50008,3649,1.07 [1.02-1.13],0.0078916164216344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSC2,Desmocollin-2,49689,3638,1.66 [1.53-1.80],4.324794276541888e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSCAM,Down syndrome cell adhesion molecule,43640,3195,1.97 [1.80-2.16],2.699826142462264e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG2,Desmoglein-2,50252,3681,0.59 [0.53-0.65],1.4941196282788529e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG3,Desmoglein-3,50504,3689,0.85 [0.78-0.92],8.863441818707522e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG4,Desmoglein-4,49849,3634,0.80 [0.75-0.85],1.2859202100872352e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTD1,D-aminoacyl-tRNA deacylase 1,42761,3137,1.06 [1.02-1.10],0.0064964240437646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTNB,Dystrobrevin beta,43436,3183,1.64 [1.53-1.75],1.7755121518823474e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTYMK,Thymidylate kinase,43722,3201,1.14 [1.09-1.20],4.07811415282416e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUSP3,Dual specificity protein phosphatase 3,49082,3568,0.95 [0.92-0.99],0.009046641962905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",43539,3194,1.10 [1.07-1.14],1.482237744931373e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DXO,Decapping and exoribonuclease protein,43613,3190,1.15 [1.06-1.23],0.0002931558603252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNLT1,Dynein light chain Tctex-type 1,42513,3125,1.13 [1.08-1.17],5.111201468508592e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNLT3,Dynein light chain Tctex-type 3,43518,3190,1.10 [1.02-1.19],0.0095490296777118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,49859,3646,1.08 [1.05-1.12],5.745844737958472e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBI3_IL27,Interleukin-27,50593,3692,1.22 [1.11-1.34],2.9584792238536367e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",43722,3201,1.34 [1.29-1.40],1.2621749951496478e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",42553,3118,1.20 [1.16-1.24],1.7640460161863045e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECI2,Enoyl-CoA delta isomerase 2,42287,3106,1.16 [1.10-1.22],2.5518185022805426e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,50668,3699,1.42 [1.32-1.53],1.8548149523317522e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDDM3B,Epididymal secretory protein E3-beta,43518,3190,0.84 [0.79-0.90],3.004501699419389e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDF1,Endothelial differentiation-related factor 1,43640,3195,1.09 [1.04-1.14],0.0001846891597107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,49323,3609,1.34 [1.23-1.45],1.8733409244929903e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDN1,Endothelin-1,42553,3118,1.47 [1.31-1.65],3.926368800158949e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EEF1D,Elongation factor 1-delta,43722,3201,1.14 [1.10-1.18],1.3604921861015838e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,43539,3194,1.24 [1.11-1.38],0.0001482623046052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFCAB2,Dynein regulatory complex protein 8,42925,3150,1.13 [1.03-1.25],0.0097709211419264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,50362,3678,1.20 [1.09-1.31],0.0001020052197681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA1,Ephrin-A1,50170,3678,1.56 [1.42-1.72],3.828589400062634e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA4,Ephrin-A4,49774,3640,2.21 [2.05-2.39],1.051780087479806e-87
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGF,Pro-epidermal growth factor,50132,3661,1.04 [1.01-1.07],0.0044276560239512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFL7,Epidermal growth factor-like protein 7,49060,3565,1.26 [1.18-1.35],7.622290050037779e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFLAM,Pikachurin,43539,3194,1.31 [1.18-1.45],2.685128312861414e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFR,Epidermal growth factor receptor,50857,3718,0.70 [0.59-0.84],0.0001215828259545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGLN1,Egl nine homolog 1,50168,3665,1.26 [1.21-1.31],6.865615027110419e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EHBP1,EH domain-binding protein 1,43722,3201,1.11 [1.07-1.16],2.091232540617556e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",43379,3178,1.07 [1.04-1.10],2.261119168675155e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4B,Eukaryotic translation initiation factor 4B,49859,3646,1.12 [1.06-1.18],2.604843699250544e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4E,Eukaryotic translation initiation factor 4E,42452,3109,1.07 [1.03-1.12],0.0002481401531171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,50238,3669,1.14 [1.09-1.19],2.4925748365132193e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,50792,3709,1.12 [1.09-1.16],9.009957476551085e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,43640,3195,1.09 [1.04-1.15],0.0004652175230467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,43640,3195,1.06 [1.02-1.10],0.0039323254289936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELOA,Elongin-A,50008,3649,1.22 [1.16-1.27],2.091822396615229e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENAH,Protein enabled homolog,49283,3574,1.16 [1.09-1.23],1.195871620797859e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENG,Endoglin,50857,3718,1.53 [1.30-1.81],3.273515025168056e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO1,Alpha-enolase,50187,3668,1.07 [1.03-1.12],0.0001802309150881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO3,Beta-enolase,42553,3118,1.32 [1.25-1.38],8.15878252088265e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,42287,3106,1.19 [1.06-1.34],0.0025807352027121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,50857,3718,1.56 [1.41-1.72],8.978645731280246e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,48684,3532,1.35 [1.31-1.40],7.835175256635761e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,49060,3565,1.47 [1.39-1.57],2.864027327165288e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,49323,3609,0.53 [0.46-0.60],7.342199937508842e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,49323,3609,1.59 [1.41-1.79],2.5685486592513203e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTR1,Endosome-associated-trafficking regulator 1,42553,3118,1.27 [1.21-1.34],8.935518820210307e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPCAM,Epithelial cell adhesion molecule,50205,3658,0.93 [0.90-0.96],1.487389589573558e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA1,Ephrin type-A receptor 1,50370,3670,1.43 [1.31-1.57],4.643363679781738e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA2,Ephrin type-A receptor 2,48418,3524,1.60 [1.47-1.75],8.993415706778226e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA4,Ephrin type-A receptor 4,42761,3137,1.29 [1.14-1.45],2.598754152203143e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB4,Ephrin type-B receptor 4,50857,3718,1.25 [1.12-1.40],0.0001002789296357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHX2,Bifunctional epoxide hydrolase 2,49323,3609,1.09 [1.05-1.14],6.91942673457167e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPO,Erythropoietin,50168,3665,1.18 [1.14-1.22],3.0234020924684988e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPPK1,Epiplakin,42553,3118,1.08 [1.04-1.13],0.0003918536342285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,50587,3697,1.96 [1.81-2.13],1.0328648202191484e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,50396,3675,2.94 [2.63-3.29],4.3136973999980925e-81
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,50040,3649,1.58 [1.37-1.83],6.65132797939751e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,50396,3675,1.70 [1.51-1.91],1.288937014361995e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBIN,Erbin,50008,3649,1.07 [1.04-1.10],7.098729741987581e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EREG,Proepiregulin,49776,3638,1.08 [1.05-1.12],8.67502464232059e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERI1,3'-5' exoribonuclease 1,42925,3150,1.17 [1.07-1.29],0.0010229418246269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERMAP,Erythroid membrane-associated protein,42452,3109,1.37 [1.27-1.48],2.8293744736548387e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,43518,3190,1.40 [1.29-1.52],1.983969467780265e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERP29,Endoplasmic reticulum resident protein 29,42761,3137,1.06 [1.03-1.09],0.0001043632342876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERP44,Endoplasmic reticulum resident protein 44,49926,3645,1.45 [1.30-1.62],7.590363266139875e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESAM,Endothelial cell-selective adhesion molecule,50857,3718,1.25 [1.15-1.37],3.561728632075476e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESM1,Endothelial cell-specific molecule 1,50204,3657,0.66 [0.60-0.71],2.6758953850798484e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESYT2,Extended synaptotagmin-2,43613,3190,1.12 [1.08-1.17],1.9075537010210363e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EVI5,Ecotropic viral integration site 5 protein homolog,42452,3109,1.08 [1.04-1.13],3.731125448163731e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EXTL1,Exostosin-like 1,42287,3106,0.84 [0.78-0.91],2.566226556231909e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EZR,Ezrin,50687,3698,1.81 [1.62-2.02],7.747700503184913e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F10,Coagulation factor X,43751,3210,1.29 [1.16-1.45],6.7706095294024205e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11,Coagulation factor XI,43150,3172,1.29 [1.17-1.41],6.89251247610767e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11R,Junctional adhesion molecule A,50252,3681,1.29 [1.23-1.35],2.582856957929084e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F13B,Coagulation factor XIII B chain,43545,3194,0.68 [0.60-0.77],4.713678194072673e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2R,Proteinase-activated receptor 1,50372,3673,1.16 [1.10-1.22],1.177222323729814e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F3,Tissue factor,50358,3675,0.76 [0.69-0.85],7.867919416431525e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F7,Coagulation factor VII,50362,3676,1.66 [1.51-1.83],4.543242069297264e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F9,Coagulation factor IX,50363,3678,3.96 [3.40-4.62],3.471567534750937e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP1,"Fatty acid-binding protein, liver",50204,3657,1.45 [1.41-1.49],4.417972179773834e-152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP2,"Fatty acid-binding protein, intestinal",50238,3669,1.10 [1.06-1.14],3.253456230100249e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP3,"Fatty acid-binding protein, heart",43722,3201,1.44 [1.36-1.53],3.786483989781998e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP4,"Fatty acid-binding protein, adipocyte",50857,3718,1.65 [1.57-1.73],3.037020461735704e-81
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP5,Fatty acid-binding protein 5,50523,3690,1.23 [1.18-1.28],1.808605495398417e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP9,Fatty acid-binding protein 9,50168,3665,0.88 [0.84-0.93],2.4533965489505745e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM13A,Protein FAM13A,43539,3194,1.11 [1.06-1.17],3.467848275793793e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM20A,Pseudokinase FAM20A,43722,3201,2.39 [2.18-2.63],6.847195033693635e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3B,Protein FAM3B,50008,3649,1.59 [1.47-1.73],8.028733982669626e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3C,Protein FAM3C,50163,3667,2.08 [1.89-2.28],1.1116498338178907e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3D,Protein FAM3D,43539,3194,1.28 [1.23-1.33],7.709913339418444e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAP,Prolyl endopeptidase FAP,50857,3718,1.20 [1.08-1.33],0.0006155105737568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,42513,3125,1.10 [1.05-1.16],2.5433780529082863e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAS,Tumor necrosis factor receptor superfamily member 6,50690,3708,1.43 [1.34-1.52],1.1891986027618908e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FASLG,Tumor necrosis factor ligand superfamily member 6,50792,3709,0.62 [0.57-0.67],4.1334300523953166e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBN2,Fibrillin-2,42513,3125,1.08 [1.02-1.15],0.0083310930761099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBP1,"Fructose-1,6-bisphosphatase 1",50238,3669,1.30 [1.25-1.34],2.714915355672566e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,43722,3201,1.67 [1.60-1.74],1.2124916880050691e-117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAR,Immunoglobulin alpha Fc receptor,50168,3665,1.41 [1.33-1.49],1.896830168365799e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,43640,3195,1.29 [1.13-1.48],0.0002414743791837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,50252,3681,1.19 [1.12-1.25],5.191953900198802e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,50033,3660,1.12 [1.07-1.18],1.4422455985831118e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,49060,3565,1.12 [1.07-1.18],7.082822720341265e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCN1,Ficolin-1,43666,3204,1.34 [1.26-1.43],1.739764940806594e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL1,Fc receptor-like protein 1,50238,3669,1.19 [1.12-1.27],3.3496726091828924e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL2,Fc receptor-like protein 2,50549,3689,1.14 [1.08-1.20],5.43612394348296e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL5,Fc receptor-like protein 5,50252,3681,1.23 [1.17-1.29],9.291326439125055e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL6,Fc receptor-like protein 6,50168,3665,1.12 [1.07-1.17],2.92790668931094e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRLB,Fc receptor-like B,49060,3565,1.20 [1.15-1.25],5.030375087602218e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FDX1,"Adrenodoxin, mitochondrial",42287,3106,1.15 [1.10-1.21],1.049221099960426e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FEN1,Flap endonuclease 1,49060,3565,1.11 [1.06-1.15],4.984188096093564e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FETUB,Fetuin-B,50363,3678,1.58 [1.43-1.74],2.1988453093475846e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGA,Fibrinogen alpha chain,42746,3124,1.28 [1.15-1.43],1.4618492682143016e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",43640,3195,1.08 [1.04-1.13],0.0001786986874529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF19,Fibroblast growth factor 19,50453,3677,0.89 [0.86-0.92],3.8400239183873644e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF2,Fibroblast growth factor 2,50168,3665,1.10 [1.05-1.14],1.1579860998606648e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF21,Fibroblast growth factor 21,50593,3692,1.29 [1.26-1.31],7.747816471355593e-107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF23,Fibroblast growth factor 23,50587,3688,1.34 [1.29-1.40],7.899590454005814e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF5,Fibroblast growth factor 5,49283,3574,1.22 [1.12-1.33],5.747684962986641e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP1,Fibroblast growth factor-binding protein 1,50396,3675,0.36 [0.33-0.39],1.2094758465695943e-136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP2,Fibroblast growth factor-binding protein 2,43726,3217,0.86 [0.81-0.92],1.597700005738935e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP3,Fibroblast growth factor-binding protein 3,43613,3190,0.72 [0.66-0.79],7.513358027385208e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR2,Fibroblast growth factor receptor 2,50396,3675,4.25 [3.83-4.73],2.679938846423656e-159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR4,Fibroblast growth factor receptor 4,42761,3137,0.88 [0.82-0.94],7.379408925143588e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGL1,Fibrinogen-like protein 1,43751,3210,1.18 [1.12-1.24],6.478184352598528e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGR,Tyrosine-protein kinase Fgr,49082,3568,1.17 [1.13-1.22],6.669455471002706e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FIS1,Mitochondrial fission 1 protein,50205,3660,1.07 [1.03-1.11],0.0006076808094485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,43640,3195,1.07 [1.03-1.10],0.0001727464839167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,49859,3646,1.33 [1.25-1.43],1.8545195275884642e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,49859,3646,1.07 [1.03-1.10],4.3606571816083445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBPL,FK506-binding protein-like,43539,3194,1.10 [1.04-1.17],0.0007282593175023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLI1,Friend leukemia integration 1 transcription factor,49060,3565,1.07 [1.04-1.09],2.4926040598595416e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,49859,3646,1.43 [1.29-1.58],3.705214644906293e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,50792,3709,1.42 [1.30-1.54],4.9509469940721e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT4,Vascular endothelial growth factor receptor 3,50396,3675,1.19 [1.09-1.30],0.000120874894329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FMNL1,Formin-like protein 1,49082,3568,1.17 [1.13-1.21],2.38481194377837e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FN1,Fibronectin,43788,3214,1.26 [1.11-1.43],0.0002742264618404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,43518,3190,1.23 [1.13-1.34],3.6789793750810434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR1,Folate receptor alpha,50164,3658,1.23 [1.11-1.35],4.764537284886922e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR2,Folate receptor beta,50687,3698,1.14 [1.04-1.26],0.0069322871681767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOXJ3,Forkhead box protein J3,42452,3109,1.18 [1.10-1.27],5.965770060243209e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOXO1,Forkhead box protein O1,50168,3665,1.05 [1.01-1.08],0.0079792315672868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FST,Follistatin,50372,3673,0.86 [0.81-0.92],1.9359998354616454e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL1,Follistatin-related protein 1,42553,3118,1.87 [1.62-2.17],5.1815614431737234e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL3,Follistatin-related protein 3,50126,3657,1.63 [1.50-1.78],9.55398579693886e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FTCD,Formimidoyltransferase-cyclodeaminase,43531,3183,1.53 [1.48-1.58],1.9320999544618823e-135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUCA1,Tissue alpha-L-fucosidase,50537,3699,1.11 [1.07-1.15],1.1479906144015689e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUOM,Fucose mutarotase,42761,3137,1.66 [1.59-1.74],1.1076035580344715e-101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FURIN,Furin,50396,3675,2.43 [2.22-2.64],3.729236529093021e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUS,RNA-binding protein FUS,48980,3554,1.20 [1.12-1.29],3.043127049769679e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,50687,3698,1.21 [1.14-1.29],3.596850094607215e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FXN,"Frataxin, mitochondrial",50668,3699,1.06 [1.02-1.10],0.005835838371724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FXYD5,FXYD domain-containing ion transport regulator 5,49283,3574,1.08 [1.03-1.13],0.0005991343993334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FYB1,FYN-binding protein 1,50168,3674,1.10 [1.07-1.14],2.309506860625621e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,42553,3118,1.12 [1.05-1.19],0.0003481590639467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAGE2A,G antigen 2A,42155,3087,1.07 [1.02-1.12],0.009710391171432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAL,Galanin peptides,50453,3677,0.81 [0.77-0.85],1.516542518966363e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,50008,3649,2.43 [2.20-2.67],7.296523324923353e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,50668,3699,0.86 [0.77-0.96],0.005401465449088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,49283,3574,1.43 [1.33-1.52],6.309388787333859e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,43722,3201,1.24 [1.10-1.38],0.0002658247066252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT7,N-acetylgalactosaminyltransferase 7,50008,3649,1.85 [1.61-2.13],9.663318256710916e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,41827,3055,1.75 [1.54-1.98],1.4075800202218623e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS2,Growth arrest-specific protein 2,42925,3150,1.23 [1.17-1.29],5.577772344235197e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS6,Growth arrest-specific protein 6,50529,3697,1.44 [1.29-1.61],2.5533204796785817e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GASK1A,Golgi-associated kinase 1A,42287,3106,1.15 [1.06-1.24],0.0006511025956437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAST,Gastrin,43613,3190,1.13 [1.11-1.16],1.294427138515391e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",42553,3118,1.08 [1.03-1.12],0.0011325733751528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP1,Guanylate-binding protein 1,43535,3187,1.20 [1.14-1.27],1.1326441135116246e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCC1,GRIP and coiled-coil domain-containing protein 1,43613,3190,1.08 [1.05-1.11],1.9651829756733866e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCG,Pro-glucagon,49060,3565,1.29 [1.26-1.32],2.141049839014907e-95
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,41714,3054,1.30 [1.22-1.38],5.1699697721038086e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",50008,3649,1.50 [1.38-1.63],4.710725912505958e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF15,Growth/differentiation factor 15,50857,3718,2.36 [2.28-2.45],0.0
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF2,Growth/differentiation factor 2,50238,3669,1.34 [1.23-1.45],1.4353006188741113e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDNF,Glial cell line-derived neurotrophic factor,49082,3568,1.52 [1.41-1.63],9.020285607022691e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GET3,ATPase GET3,43722,3201,1.08 [1.02-1.15],0.0073282341810479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFER,FAD-linked sulfhydryl oxidase ALR,49060,3565,1.25 [1.19-1.31],3.2331889394436293e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA1,GDNF family receptor alpha-1,50593,3692,2.56 [2.33-2.81],2.773538241316363e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRAL,GDNF family receptor alpha-like,42317,3100,0.86 [0.81-0.91],7.497894936286657e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGH,Gamma-glutamyl hydrolase,49389,3606,1.71 [1.58-1.85],2.093869200238438e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT1,Glutathione hydrolase 1 proenzyme,50170,3678,1.78 [1.69-1.86],1.4491094088070939e-125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT5,Glutathione hydrolase 5 proenzyme,49859,3646,2.35 [2.12-2.62],6.209490071798801e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GH1,Somatotropin,50163,3667,0.97 [0.95-0.99],0.0003158044133084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHR,Growth hormone receptor,42761,3137,2.13 [1.88-2.41],5.5816890688279406e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRL,Appetite-regulating hormone,50238,3669,0.84 [0.81-0.87],3.2093008711382182e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIGYF2,GRB10-interacting GYF protein 2,43640,3195,1.15 [1.10-1.20],2.667941159576144e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP7,GTPase IMAP family member 7,42761,3137,0.69 [0.61-0.78],6.425704677203812e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP8,GTPase IMAP family member 8,42155,3087,1.16 [1.09-1.24],1.7721332822840806e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIP,Gastric inhibitory polypeptide,42553,3118,1.21 [1.14-1.29],7.81265704901324e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC2,PDZ domain-containing protein GIPC2,43613,3190,1.71 [1.54-1.89],4.217767460762416e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIT1,ARF GTPase-activating protein GIT1,42452,3109,1.06 [1.02-1.09],0.0033304726503272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GKN1,Gastrokine-1,48140,3498,1.27 [1.14-1.41],9.694677647958537e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLA,Alpha-galactosidase A,42684,3133,2.26 [2.09-2.45],9.521060058386463e-91
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLB1,Beta-galactosidase,49859,3646,1.60 [1.50-1.71],4.432008429710156e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLO1,Lactoylglutathione lyase,49323,3609,1.19 [1.13-1.25],1.043383937122299e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLOD4,Glyoxalase domain-containing protein 4,50124,3656,1.14 [1.05-1.24],0.0015420050111682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLRX,Glutaredoxin-1,49918,3648,1.08 [1.03-1.14],0.0020943182377257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",42761,3137,1.06 [1.02-1.10],0.0034949681561573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GM2A,Ganglioside GM2 activator,42660,3143,1.13 [1.04-1.22],0.0024820036221642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GMPR2,GMP reductase 2,42761,3137,1.12 [1.06-1.18],1.4223290847198048e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,49060,3565,1.06 [1.02-1.11],0.0075114514032509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLGA3,Golgin subfamily A member 3,43640,3195,1.09 [1.05-1.14],6.347764448073687e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLM2,Protein GOLM2,50687,3698,2.75 [2.52-3.00],1.857387760907632e-113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,50168,3665,1.05 [1.02-1.08],0.0009346114918114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GORASP2,Golgi reassembly-stacking protein 2,43539,3194,1.13 [1.05-1.21],0.000539370947702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOT1,"Aspartate aminotransferase, cytoplasmic",43726,3217,1.33 [1.24-1.43],2.351475692323899e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP1BA,Platelet glycoprotein Ib alpha chain,50033,3657,0.87 [0.80-0.95],0.0026251305248323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,48686,3564,1.06 [1.03-1.10],0.0003379324430912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP5,Platelet glycoprotein V,42761,3137,1.13 [1.03-1.25],0.0097292260119317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPA33,Cell surface A33 antigen,50008,3649,0.92 [0.90-0.94],1.2307741468705866e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC1,Glypican-1,50668,3699,1.18 [1.07-1.31],0.0006387654922766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC5,Glypican-5,49859,3646,0.90 [0.85-0.94],3.787416866499025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPD1,Glycerol-3-phosphate dehydrogenase,43518,3190,1.84 [1.75-1.94],5.27372713369695e-123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPHA2,Glycoprotein hormone alpha-2,43539,3194,0.89 [0.83-0.97],0.0060958524021389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPI,Glucose-6-phosphate isomerase,43751,3210,1.30 [1.21-1.39],3.79509567786227e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,43539,3194,0.91 [0.87-0.96],9.782664417970148e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPKOW,G-patch domain and KOW motifs-containing protein,49082,3568,1.42 [1.32-1.53],6.288457760293069e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPNMB,Transmembrane glycoprotein NMB,48875,3572,1.87 [1.69-2.08],5.061851488963389e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR158,Probable G-protein coupled receptor 158,43640,3195,0.78 [0.70-0.87],3.413493646312586e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR15L,Protein GPR15L,43539,3194,1.10 [1.04-1.16],0.0005876617065369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR37,Prosaposin receptor GPR37,49323,3609,1.38 [1.32-1.44],6.821593012389591e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPRC5C,G-protein coupled receptor family C group 5 member C,43518,3190,1.45 [1.38-1.51],2.3598351418066622e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRAP2,GRB2-related adapter protein 2,50238,3669,1.03 [1.01-1.06],0.003373730928756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,43722,3201,1.28 [1.22-1.35],1.6036016629169936e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRN,Progranulin,50008,3667,2.00 [1.79-2.24],2.7628953528110344e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",50008,3649,1.41 [1.35-1.47],3.4838015320403375e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSN,Gelsolin,43585,3200,0.39 [0.36-0.42],3.358803603062163e-117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSR,"Glutathione reductase, mitochondrial",43500,3191,1.24 [1.07-1.45],0.0045500367241863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA1,Glutathione S-transferase A1,50161,3662,1.47 [1.42-1.51],1.9898715362478176e-137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA3,Glutathione S-transferase A3,49060,3565,1.43 [1.38-1.47],1.4699783403122694e-102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUSB,Beta-glucuronidase,50455,3692,1.80 [1.73-1.88],1.1533003737816471e-166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMA,Granzyme A,50792,3709,1.49 [1.38-1.61],1.1913276845233197e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMH,Granzyme H,49323,3609,1.06 [1.02-1.10],0.0023024423795929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAO1,Hydroxyacid oxidase 1,50668,3699,1.29 [1.27-1.32],2.610251593839759e-123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",50252,3681,1.08 [1.04-1.12],6.157733567021421e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR1,Hepatitis A virus cellular receptor 1,50596,3696,1.74 [1.68-1.81],2.066677692649901e-175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR2,Hepatitis A virus cellular receptor 2,50252,3681,1.70 [1.58-1.84],8.262499703013904e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBEGF,Proheparin-binding EGF-like growth factor,50521,3689,1.10 [1.06-1.15],1.1830132326005308e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBQ1,Hemoglobin subunit theta-1,50668,3699,0.91 [0.86-0.95],4.080891387913999e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HCLS1,Hematopoietic lineage cell-specific protein,50792,3709,1.12 [1.06-1.18],4.022759424532139e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,43613,3190,1.19 [1.13-1.25],6.403616995033347e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEG1,Protein HEG homolog 1,42761,3137,3.43 [3.05-3.85],3.678476259156471e-95
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPACAM2,HEPACAM family member 2,43613,3190,0.89 [0.82-0.96],0.0035606743452419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPH,Hephaestin,43722,3201,3.33 [2.92-3.81],9.13218325960017e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEXIM1,Protein HEXIM1,50168,3665,1.12 [1.08-1.16],7.342655574682064e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGF,Hepatocyte growth factor,50792,3709,2.78 [2.60-2.97],6.493360594969362e-197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,49060,3565,1.06 [1.02-1.10],0.0026204150719522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,43613,3190,1.23 [1.17-1.28],5.581762860258202e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1R,Huntingtin-interacting protein 1-related protein,43529,3184,1.50 [1.43-1.58],4.637421359336411e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HJV,Hemojuvelin,43640,3195,1.42 [1.34-1.50],4.170773641932457e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",43640,3195,1.18 [1.06-1.30],0.002000519665533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",50018,3658,1.33 [1.23-1.44],4.975019740302707e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",50168,3665,1.22 [1.11-1.35],5.5550649906965614e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMCN2,Hemicentin-2,42685,3133,1.30 [1.23-1.38],6.772515303530331e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",42553,3118,1.10 [1.03-1.18],0.0050610647027814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX1,Heme oxygenase 1,49672,3635,0.87 [0.82-0.93],1.3221558019798112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX2,Heme oxygenase 2,49082,3568,1.16 [1.09-1.23],1.54458941744048e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNMT,Histamine N-methyltransferase,49620,3630,1.51 [1.42-1.60],3.83286904609205e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,49162,3599,1.08 [1.04-1.12],7.791071544357755e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,43640,3195,1.24 [1.17-1.32],1.898938978900387e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPGDS,Hematopoietic prostaglandin D synthase,49060,3565,0.75 [0.69-0.81],2.552730960118784e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPSE,Heparanase,43147,3178,1.12 [1.08-1.16],3.554044826507978e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,42553,3118,0.73 [0.66-0.82],4.226797641716881e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRG,Histidine-rich glycoprotein,43545,3194,1.46 [1.31-1.62],3.118196887415476e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,50008,3649,1.25 [1.16-1.35],8.310298038727235e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,50668,3699,1.26 [1.16-1.36],2.233951384165493e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,42452,3109,1.37 [1.25-1.50],6.256091723274857e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSBP1,Heat shock factor-binding protein 1,42553,3118,1.07 [1.03-1.11],0.0003977057039712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,50168,3665,0.46 [0.43-0.49],1.460369707200906e-106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,43613,3190,1.36 [1.29-1.43],4.006475918222018e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,42553,3118,1.14 [1.07-1.22],0.0001821624633707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA1A,Heat shock 70 kDa protein 1A,50370,3670,1.12 [1.08-1.17],8.144211511045827e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA2,Heat shock-related 70 kDa protein 2,43518,3190,1.23 [1.13-1.35],1.5396403294982128e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB1,Heat shock protein beta-1,49438,3608,1.08 [1.04-1.13],0.0003686849358326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB6,Heat shock protein beta-6,50668,3699,1.35 [1.26-1.45],1.55440162669722e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,49868,3641,1.23 [1.10-1.37],0.0002448249011545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HTRA2,"Serine protease HTRA2, mitochondrial",50396,3675,1.10 [1.05-1.15],7.781622152423861e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYAL1,Hyaluronidase-1,49964,3638,2.13 [1.90-2.40],5.180019351640953e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM1,Intercellular adhesion molecule 1,50033,3655,2.50 [2.29-2.74],7.587113196830127e-93
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM3,Intercellular adhesion molecule 3,50857,3718,1.25 [1.12-1.39],6.205783421166e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM4,Intercellular adhesion molecule 4,50168,3665,0.75 [0.71-0.79],1.0057826047137012e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM5,Intercellular adhesion molecule 5,50238,3669,1.23 [1.15-1.31],2.1717676547774517e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,49082,3568,1.11 [1.05-1.18],0.0003550898392114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDO1,"Indoleamine 2,3-dioxygenase 1",42553,3118,1.13 [1.07-1.19],8.710065949953557e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDS,Iduronate 2-sulfatase,50792,3709,0.51 [0.37-0.70],2.317465639906977e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDUA,Alpha-L-iduronidase,50668,3699,1.78 [1.67-1.90],4.1574604531791727e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,42493,3114,1.88 [1.74-2.03],8.324533902333631e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNAR1,Interferon alpha/beta receptor 1,43539,3194,1.20 [1.06-1.37],0.0053747824244348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNG,Interferon gamma,49283,3574,1.04 [1.01-1.07],0.0038661402202528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR2,Interferon gamma receptor 2,49859,3646,1.49 [1.41-1.57],4.0328889249275466e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNL1,Interferon lambda-1,49082,3568,1.17 [1.09-1.24],2.569298117962408e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNLR1,Interferon lambda receptor 1,50168,3665,1.37 [1.28-1.47],1.1562953083303524e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGBP1,Immunoglobulin-binding protein 1,43640,3195,1.08 [1.03-1.14],0.0040301260641248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,43726,3217,0.69 [0.61-0.78],5.030153185062442e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF1R,Insulin-like growth factor 1 receptor,50008,3649,1.36 [1.20-1.53],9.831742305391647e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2R,Cation-independent mannose-6-phosphate receptor,50252,3681,2.83 [2.51-3.19],4.940067535151308e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP1,Insulin-like growth factor-binding protein 1,50777,3715,0.76 [0.74-0.78],1.794352757069415e-110
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP2,Insulin-like growth factor-binding protein 2,50777,3713,0.62 [0.59-0.65],1.6862413151130978e-93
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP3,Insulin-like growth factor-binding protein 3,50445,3682,0.87 [0.80-0.95],0.0018236108200251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP4,Insulin-like growth factor-binding protein 4,49611,3635,1.49 [1.40-1.58],3.205379192705567e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP7,Insulin-like growth factor-binding protein 7,50857,3718,1.86 [1.73-1.99],2.593988773994101e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,50238,3669,1.97 [1.82-2.12],1.3763436936343657e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGLC2,Immunoglobulin lambda constant 2,43714,3206,1.39 [1.26-1.54],3.483833270129549e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF3,Immunoglobulin superfamily member 3,50008,3649,2.36 [2.26-2.47],0.0
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF8,Immunoglobulin superfamily member 8,50238,3669,1.98 [1.82-2.16],8.679763807496772e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF9,Protein turtle homolog A,43722,3201,1.83 [1.77-1.90],9.533084226438716e-256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IKBKG,NF-kappa-B essential modulator,50168,3665,1.07 [1.04-1.11],1.50778376411652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10,Interleukin-10,49283,3574,1.10 [1.07-1.14],8.530298682970122e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RB,Interleukin-10 receptor subunit beta,50453,3677,2.00 [1.85-2.16],6.424960744398011e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12A_IL12B,Interleukin-12,50008,3649,1.23 [1.19-1.28],3.802936830775984e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12B,Interleukin-12 subunit beta,50792,3709,1.33 [1.27-1.40],1.7041512495904544e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB1,Interleukin-12 receptor subunit beta-1,49283,3574,1.49 [1.38-1.60],3.919712255756959e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,49614,3618,1.99 [1.75-2.27],7.36563678047225e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15,Interleukin-15,50168,3665,1.20 [1.10-1.31],2.9014321182758568e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15RA,Interleukin-15 receptor subunit alpha,49283,3574,1.22 [1.12-1.33],4.230276016389511e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL16,Pro-interleukin-16,50792,3709,1.27 [1.20-1.36],5.1639063305028884e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17A,Interleukin-17A,49206,3566,1.17 [1.10-1.25],4.404223595313258e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17C,Interleukin-17C,49283,3574,1.18 [1.14-1.23],8.85351305943783e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RA,Interleukin-17 receptor A,50252,3681,1.21 [1.13-1.29],8.68424263110098e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RB,Interleukin-17 receptor B,49538,3627,0.70 [0.66-0.74],2.533123297175219e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18,Interleukin-18,50037,3648,1.50 [1.42-1.59],6.292197660534277e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18BP,Interleukin-18-binding protein,50445,3682,1.79 [1.65-1.95],4.3345147788321967e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18R1,Interleukin-18 receptor 1,50792,3709,3.68 [3.41-3.98],2.6161748752156215e-237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL19,Interleukin-19,48982,3586,1.17 [1.12-1.21],1.3955498351374588e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R1,Interleukin-1 receptor type 1,50170,3678,2.44 [2.18-2.75],3.7328919635239134e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R2,Interleukin-1 receptor type 2,50121,3651,4.05 [3.50-4.69],5.180178842737757e-79
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RAP,Interleukin-1 receptor accessory protein,50252,3681,0.87 [0.81-0.92],2.195556984401132e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL1,Interleukin-1 receptor-like 1,50690,3708,1.47 [1.38-1.56],8.109360131153547e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL2,Interleukin-1 receptor-like 2,49283,3574,1.18 [1.09-1.27],4.425024863472707e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RN,Interleukin-1 receptor antagonist protein,50124,3653,1.72 [1.65-1.78],2.2296978474772668e-167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL22,Interleukin-22,43518,3190,1.15 [1.10-1.21],3.1693213440825563e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RA,Interleukin-2 receptor subunit alpha,49882,3650,1.29 [1.21-1.38],2.409429775102728e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL31RA,Interleukin-31 receptor subunit alpha,42289,3094,1.20 [1.10-1.31],3.699094514615496e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL36G,Interleukin-36 gamma,42283,3100,1.07 [1.02-1.12],0.0052271805381759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL3RA,Interleukin-3 receptor subunit alpha,49283,3574,1.19 [1.09-1.30],0.000172570768884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL4R,Interleukin-4 receptor subunit alpha,50168,3665,1.34 [1.24-1.44],8.162993595457162e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5RA,Interleukin-5 receptor subunit alpha,50168,3665,1.15 [1.10-1.21],2.025542432394969e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6,Interleukin-6,50008,3649,1.25 [1.21-1.29],2.8718599603934173e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6ST,Interleukin-6 receptor subunit beta,50238,3669,2.20 [1.92-2.53],6.23085413737293e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL7R,Interleukin-7 receptor subunit alpha,50252,3681,0.81 [0.77-0.86],5.19256228425351e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,49005,3562,1.13 [1.07-1.19],1.6026265326153415e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMMT,MICOS complex subunit MIC60,43518,3190,1.59 [1.50-1.68],1.6227443587482272e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ING1,Inhibitor of growth protein 1,48999,3560,1.10 [1.03-1.16],0.0024306390161656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBB,Inhibin beta B chain,42761,3137,1.28 [1.20-1.36],1.878415464155205e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBC,Inhibin beta C chain,50252,3681,2.28 [2.10-2.46],2.234399403706181e-93
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",42553,3118,1.26 [1.19-1.33],8.895633124961327e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",50008,3649,1.08 [1.05-1.11],5.689575690430158e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL3,Insulin-like 3,43613,3190,0.87 [0.84-0.91],3.1188941147071653e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL5,Insulin-like peptide INSL5,43539,3194,1.17 [1.14-1.21],4.590075944975401e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSR,Insulin receptor,42452,3109,1.66 [1.36-2.01],4.122839928275543e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,49774,3640,1.11 [1.07-1.14],1.75562095722224e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,50008,3649,1.25 [1.18-1.31],7.507001110869886e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",49323,3609,1.06 [1.03-1.10],0.0001489369032238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAK1,Interleukin-1 receptor-associated kinase 1,49283,3574,1.09 [1.05-1.14],5.332724113456875e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAK4,Interleukin-1 receptor-associated kinase 4,50168,3665,1.05 [1.02-1.08],0.000845316189552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ISM1,Isthmin-1,50168,3665,1.21 [1.13-1.31],3.113460316636487e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IST1,IST1 homolog,43223,3170,1.06 [1.02-1.10],0.0009538307256596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA11,Integrin alpha-11,50168,3665,0.63 [0.58-0.68],7.120811145310612e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA2,Integrin alpha-2,42761,3137,0.78 [0.71-0.86],1.2138568902550192e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA5,Integrin alpha-5,50252,3681,3.26 [2.93-3.63],3.3697416903544968e-102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAL,Integrin alpha-L,42452,3109,1.35 [1.24-1.46],5.362819738873304e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAM,Integrin alpha-M,50252,3681,1.45 [1.33-1.59],1.9236221366293503e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAV,Integrin alpha-V,50668,3699,0.36 [0.31-0.43],6.141957792907974e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB2,Integrin beta-2,49946,3662,1.94 [1.76-2.14],5.991957854491848e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB6,Integrin beta-6,49283,3574,1.43 [1.29-1.57],1.4769673455087609e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB7,Integrin beta-7,50668,3699,1.29 [1.22-1.37],1.5469549498860942e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGBL1,Integrin beta-like protein 1,43726,3217,2.07 [1.93-2.22],2.0087063532749038e-91
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITM2A,Integral membrane protein 2A,50168,3665,0.93 [0.88-0.97],0.0023685015160257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",42553,3118,1.12 [1.07-1.17],1.6962818536410497e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM2,Junctional adhesion molecule B,50687,3698,1.25 [1.12-1.39],4.1941460366038345e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM3,Junctional adhesion molecule C,42761,3137,1.14 [1.07-1.22],5.472367405255552e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JUN,Transcription factor AP-1,49283,3574,1.09 [1.03-1.16],0.0020508254199973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KAZN,Kazrin,43539,3194,1.06 [1.03-1.10],0.0002194289412127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCTD5,BTB/POZ domain-containing protein KCTD5,42788,3131,1.39 [1.31-1.48],4.942629562187759e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KDR,Vascular endothelial growth factor receptor 2,50396,3675,1.33 [1.18-1.49],2.7983728368041137e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KEL,Kell blood group glycoprotein,49082,3568,1.21 [1.12-1.31],3.639978916686944e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHK,Ketohexokinase,42553,3118,1.68 [1.59-1.77],3.535885730443956e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA0319,Dyslexia-associated protein KIAA0319,43613,3190,0.64 [0.57-0.72],3.4290946992949033e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF1C,Kinesin-like protein KIF1C,42287,3106,1.21 [1.11-1.32],1.6722143055012745e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF22,Kinesin-like protein KIF22,42287,3106,1.11 [1.08-1.14],5.991123813905415e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIFBP,KIF-binding protein,50008,3649,1.08 [1.04-1.12],2.2771226441562583e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,43518,3190,1.05 [1.01-1.09],0.0094029787987114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,49060,3565,1.05 [1.02-1.09],0.0060110136733384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIRREL2,Kin of IRRE-like protein 2,49082,3568,0.86 [0.80-0.92],5.454971004133252e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIT,Mast/stem cell growth factor receptor Kit,50363,3678,0.62 [0.56-0.68],1.971885227993732e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KITLG,Kit ligand,50238,3669,0.57 [0.53-0.61],5.121775199498709e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLB,Beta-klotho,49082,3568,0.88 [0.84-0.92],5.18223731114421e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLF4,Krueppel-like factor 4,42308,3098,1.15 [1.06-1.25],0.0005457840841689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK11,Kallikrein-11,49914,3633,1.14 [1.04-1.25],0.0059954829136782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK14,Kallikrein-14,50668,3699,0.76 [0.72-0.81],1.477725815769581e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK3,Prostate-specific antigen,43726,3217,0.93 [0.90-0.96],4.642147564648437e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK4,Kallikrein-4,50668,3699,1.14 [1.09-1.19],4.932105775137127e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK7,Kallikrein-7,41664,3056,0.74 [0.68-0.81],2.0515120526990862e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLKB1,Plasma kallikrein,42894,3146,1.22 [1.06-1.40],0.0041519168719034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,50792,3709,1.92 [1.79-2.06],1.657356096553287e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRD1,Natural killer cells antigen CD94,50792,3709,1.23 [1.16-1.31],2.6167514143142123e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,42452,3109,1.24 [1.17-1.32],6.982087714305289e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRK1,NKG2-D type II integral membrane protein,43613,3190,1.22 [1.14-1.31],5.1656270460588223e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT18,"Keratin, type I cytoskeletal 18",50008,3649,1.51 [1.47-1.55],1.2805610807751077e-179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT19,"Keratin, type I cytoskeletal 19",50085,3656,1.32 [1.27-1.37],4.0516457234323206e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT5,"Keratin, type II cytoskeletal 5",49082,3568,0.87 [0.82-0.93],1.2560138514143763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT8,"Keratin, type II cytoskeletal 8",42308,3098,1.34 [1.30-1.37],1.267768168043227e-112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,50154,3665,1.11 [1.06-1.17],4.4371417113206096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYNU,Kynureninase,50792,3709,1.77 [1.67-1.87],1.0339291274950169e-83
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,L1CAM,Neural cell adhesion molecule L1,50396,3675,1.16 [1.05-1.29],0.0026130576948094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,43722,3201,1.09 [1.05-1.13],4.594782982590849e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LACRT,Extracellular glycoprotein lacritin,43438,3179,0.85 [0.79-0.93],0.0001055753376632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LACTB2,Endoribonuclease LACTB2,50238,3669,1.07 [1.03-1.12],0.0019609037518325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAG3,Lymphocyte activation gene 3 protein,50008,3649,1.29 [1.21-1.38],6.342584227484654e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,50204,3657,1.37 [1.29-1.45],1.4275598366344838e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,49859,3646,1.04 [1.01-1.07],0.0074496562872228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMB1,Laminin subunit beta-1,42553,3118,2.37 [2.12-2.66],1.850817025978307e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP1,Lysosome-associated membrane glycoprotein 1,42504,3133,1.45 [1.36-1.55],2.3464514525571924e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP2,Lysosome-associated membrane glycoprotein 2,48716,3565,3.08 [2.65-3.58],2.9163727023559363e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP3,Lysosome-associated membrane glycoprotein 3,50709,3703,1.18 [1.11-1.24],3.395818790228667e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAP3,Cytosol aminopeptidase,49283,3574,1.22 [1.15-1.29],1.3815173552651319e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LARP1,La-related protein 1,43518,3190,1.10 [1.05-1.16],0.000205269457832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAT,Linker for activation of T-cells family member 1,50792,3709,1.13 [1.08-1.17],1.5039284505063695e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAT2,Linker for activation of T-cells family member 2,50008,3649,1.08 [1.05-1.10],5.567543904447295e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LATS1,Serine/threonine-protein kinase LATS1,42452,3109,1.13 [1.09-1.18],7.483079819262585e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAYN,Layilin,49776,3638,1.38 [1.27-1.50],3.458300572414656e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBP,Lipopolysaccharide-binding protein,50445,3682,1.31 [1.24-1.37],6.16922217670796e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBR,Delta(14)-sterol reductase LBR,50687,3698,1.21 [1.16-1.25],1.7686431498224604e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCAT,Phosphatidylcholine-sterol acyltransferase,43751,3210,2.22 [1.90-2.61],4.839214370010137e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN15,Lipocalin-15,43640,3195,1.16 [1.11-1.22],6.351141864592652e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN2,Neutrophil gelatinase-associated lipocalin,48730,3557,1.16 [1.08-1.25],5.362587889835214e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLR,Low-density lipoprotein receptor,50367,3678,1.41 [1.34-1.49],5.1543743231877e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,43640,3195,1.06 [1.03-1.10],0.0003299997423826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LECT2,Leukocyte cell-derived chemotaxin-2,43722,3201,1.21 [1.15-1.27],8.67337327814515e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEO1,RNA polymerase-associated protein LEO1,43640,3195,1.30 [1.20-1.42],1.126721343868466e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEP,Leptin,50238,3669,1.31 [1.26-1.38],4.461906461565408e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEPR,Leptin receptor,50238,3669,0.82 [0.74-0.90],3.388329006034684e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LETM1,Mitochondrial proton/calcium exchanger protein,43640,3195,1.27 [1.20-1.34],1.883520510437464e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS1,Galectin-1,50238,3669,1.27 [1.17-1.38],1.3754103606736104e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3,Galectin-3,50370,3677,1.22 [1.11-1.34],7.038615299221255e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3BP,Galectin-3-binding protein,43788,3214,1.88 [1.74-2.03],7.743962204188707e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS4,Galectin-4,50204,3657,2.22 [2.12-2.32],2.508572268440556e-265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS7_LGALS7B,Galectin-7,50096,3657,0.87 [0.81-0.93],7.84728676871125e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS8,Galectin-8,50687,3698,1.10 [1.05-1.16],3.649363165007121e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS9,Galectin-9,50207,3663,1.88 [1.73-2.05],6.734241785988882e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGMN,Legumain,50453,3677,1.54 [1.43-1.67],1.808313819570952e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIF,Leukemia inhibitory factor,49082,3568,1.20 [1.14-1.26],3.886771443579815e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIFR,Leukemia inhibitory factor receptor,50168,3665,2.53 [2.28-2.81],1.034417075534943e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,50252,3681,1.31 [1.21-1.42],3.304353399106961e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,50163,3667,1.74 [1.60-1.91],1.383267200254347e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,43722,3201,1.09 [1.04-1.14],0.0001725282917337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,50857,3718,1.77 [1.59-1.96],1.0714268002365268e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,50610,3703,1.46 [1.34-1.59],1.0868594083535408e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,49283,3574,1.32 [1.24-1.41],3.074077213894648e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIPF,Gastric triacylglycerol lipase,42553,3118,1.16 [1.10-1.23],3.398538714317852e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMNB2,Lamin-B2,43613,3190,1.45 [1.30-1.63],1.4777590827919959e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LONP1,"Lon protease homolog, mitochondrial",42553,3118,1.13 [1.09-1.17],5.56907150952859e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,50008,3649,1.18 [1.12-1.25],2.249191841917741e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPL,Lipoprotein lipase,50238,3669,0.52 [0.50-0.54],5.590254146516913e-190
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPO,Lactoperoxidase,48591,3561,1.40 [1.33-1.46],8.278796005002135e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,42287,3106,1.23 [1.17-1.29],1.0337612473830369e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,50521,3689,1.17 [1.08-1.27],0.0001593756583847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,42303,3100,1.46 [1.32-1.62],2.728320234901751e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,50008,3649,0.85 [0.76-0.95],0.0032556696957719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP11,Low-density lipoprotein receptor-related protein 11,50238,3669,1.48 [1.37-1.60],3.802367097945989e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,50687,3698,1.07 [1.02-1.13],0.0035171752775371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC25,Leucine-rich repeat-containing protein 25,50008,3649,1.27 [1.18-1.36],7.836814568974417e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,43539,3194,1.22 [1.13-1.32],7.960760703421466e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC38,Leucine-rich repeat-containing protein 38,42513,3125,1.11 [1.04-1.19],0.0024211125926042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC59,Leucine-rich repeat-containing protein 59,43722,3201,1.19 [1.11-1.27],3.157938516426747e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,43518,3190,1.19 [1.11-1.27],4.811265250079617e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRN1,Leucine-rich repeat neuronal protein 1,49283,3574,0.85 [0.78-0.91],1.2004358908477344e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,43640,3195,0.70 [0.61-0.80],2.943557241701117e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LSP1,Lymphocyte-specific protein 1,50168,3665,1.38 [1.28-1.48],2.1794271480779243e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTA,Lymphotoxin-alpha,50168,3665,1.12 [1.04-1.21],0.0017813381837815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,49060,3565,1.32 [1.26-1.38],2.650571230161441e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBR,Tumor necrosis factor receptor superfamily member 3,49956,3640,1.27 [1.15-1.41],1.397606321316092e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LXN,Latexin,49626,3624,0.94 [0.90-0.98],0.0032265987079883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY6D,Lymphocyte antigen 6D,49963,3642,0.85 [0.78-0.92],3.77784049265172e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY75,Lymphocyte antigen 75,50168,3665,1.13 [1.04-1.22],0.0021328569789565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY9,T-lymphocyte surface antigen Ly-9,49651,3617,1.49 [1.36-1.65],3.002808065824109e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY96,Lymphocyte antigen 96,49859,3646,1.45 [1.34-1.56],3.9590071065190424e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYN,Tyrosine-protein kinase Lyn,50008,3649,1.09 [1.05-1.13],1.7952435233375905e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD3,Ly6/PLAUR domain-containing protein 3,49999,3640,1.50 [1.38-1.63],9.100343793277605e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD8,Ly6/PLAUR domain-containing protein 8,49060,3565,1.17 [1.11-1.23],3.057048550370846e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,43788,3214,1.37 [1.15-1.62],0.0002965656402832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LZTFL1,Leucine zipper transcription factor-like protein 1,42761,3137,1.10 [1.05-1.15],0.0001190827743767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,M6PR,Cation-dependent mannose-6-phosphate receptor,42553,3118,1.16 [1.07-1.26],0.0001940140389793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,49695,3632,1.34 [1.28-1.40],2.4377164109679102e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC2,MAM domain-containing protein 2,43722,3201,1.26 [1.15-1.38],1.1822480465067475e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC4,Apical endosomal glycoprotein,43518,3190,1.51 [1.43-1.60],1.0404315265994692e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN2B2,Epididymis-specific alpha-mannosidase,43722,3201,1.45 [1.37-1.54],2.3016679710661874e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,50453,3677,1.04 [1.01-1.07],0.0017864491612271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANSC4,MANSC domain-containing protein 4,42287,3106,1.08 [1.02-1.13],0.004540428310932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2,Microtubule-associated protein 2,43613,3190,1.23 [1.15-1.31],1.547872084234542e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,43539,3194,1.08 [1.02-1.14],0.0055160108470301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,49776,3638,1.05 [1.02-1.07],0.0010270133885542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPK13,Mitogen-activated protein kinase 13,42155,3087,1.15 [1.07-1.24],0.0002189476405896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPK9,Mitogen-activated protein kinase 9,50168,3665,1.10 [1.03-1.18],0.0056017535169386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MARCO,Macrophage receptor MARCO,50238,3669,1.71 [1.53-1.92],2.3950354313634977e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",42684,3133,1.09 [1.05-1.13],2.6873442804500903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MASP1,Mannan-binding lectin serine protease 1,49776,3638,2.31 [2.04-2.61],7.339089454078307e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN2,Matrilin-2,50288,3666,1.23 [1.12-1.36],2.055515288099724e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN3,Matrilin-3,49774,3640,0.49 [0.45-0.53],1.02381656199337e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAVS,Mitochondrial antiviral-signaling protein,49060,3565,1.05 [1.02-1.09],0.0017583574089856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAX,Protein max,49082,3568,1.05 [1.02-1.08],0.000332560766151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MB,Myoglobin,50857,3718,1.10 [1.04-1.15],0.0004964701111067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCAM,Cell surface glycoprotein MUC18,50445,3682,0.68 [0.62-0.74],1.3449990305714e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCEMP1,Mast cell-expressed membrane protein 1,42452,3109,1.10 [1.06-1.14],1.1560141157604305e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCFD2,Multiple coagulation factor deficiency protein 2,50005,3648,1.15 [1.07-1.22],4.307520152556511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,49859,3646,1.16 [1.11-1.20],6.456474399267306e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDH1,"Malate dehydrogenase, cytoplasmic",43507,3192,1.17 [1.08-1.27],0.0001253436106516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDK,Midkine,50242,3666,1.26 [1.20-1.33],1.5813432939883065e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",42553,3118,1.09 [1.05-1.13],3.804605147763121e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,50690,3708,1.91 [1.69-2.17],5.541281119850154e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MENT,Protein MENT,42761,3137,0.30 [0.27-0.35],2.2384847870743968e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1A,Meprin A subunit alpha,43539,3194,1.34 [1.29-1.40],7.83941503454564e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEPE,Matrix extracellular phosphoglycoprotein,50204,3657,0.67 [0.60-0.75],3.715372995510465e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MERTK,Tyrosine-protein kinase Mer,50792,3709,1.32 [1.18-1.48],1.138729304991758e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MESD,LRP chaperone MESD,50252,3681,1.04 [1.01-1.06],0.0014716770627526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MET,Hepatocyte growth factor receptor,50373,3684,0.30 [0.26-0.35],2.9319593599547623e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",50168,3665,1.07 [1.04-1.11],6.389523123062259e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP2,Methionine aminopeptidase 2,50593,3692,1.15 [1.09-1.22],1.1116721512065629e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP4,Microfibril-associated glycoprotein 4,42761,3137,1.92 [1.73-2.13],7.817208272140953e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP5,Microfibrillar-associated protein 5,50857,3718,1.15 [1.07-1.24],8.357308737152016e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFGE8,Lactadherin,50252,3681,2.06 [1.94-2.18],2.322422264144555e-133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MGLL,Monoglyceride lipase,50372,3673,1.05 [1.01-1.08],0.0058994605547235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,50168,3665,1.03 [1.01-1.06],0.0097493989980107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MIA,Melanoma-derived growth regulatory protein,50396,3675,0.81 [0.75-0.88],4.942806388738853e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,50168,3665,1.07 [1.05-1.10],2.5662724852159926e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MIF,Macrophage migration inhibitory factor,50167,3671,1.10 [1.05-1.14],4.5299052238476126e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MILR1,Allergin-1,49283,3574,1.28 [1.21-1.36],5.376034219922561e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MINK1,Misshapen-like kinase 1,43613,3190,1.08 [1.04-1.12],2.110287663623466e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MITD1,MIT domain-containing protein 1,49859,3646,1.05 [1.02-1.08],0.0012821521042235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLN,Promotilin,50168,3665,1.13 [1.09-1.17],4.129618313237961e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MME,Neprilysin,50008,3649,1.44 [1.39-1.49],4.156430958638039e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP1,Interstitial collagenase,48424,3556,1.08 [1.04-1.11],1.607709695647181e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP10,Stromelysin-2,50120,3652,1.13 [1.07-1.18],1.4200509113824914e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP12,Macrophage metalloelastase,50281,3675,1.52 [1.45-1.60],7.291133347749986e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP13,Collagenase 3,49082,3568,0.83 [0.75-0.91],5.481198881110858e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP3,Stromelysin-1,50252,3681,0.92 [0.87-0.98],0.0053257891598658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP7,Matrilysin,49246,3605,1.69 [1.59-1.80],5.423569655496496e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP8,Neutrophil collagenase,50605,3694,1.23 [1.18-1.28],2.4473426612737687e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP9,Matrix metalloproteinase-9,50168,3675,1.30 [1.24-1.37],2.324693325944223e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MNDA,Myeloid cell nuclear differentiation antigen,50161,3662,1.07 [1.05-1.10],1.664187077319123e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MOCS2,Molybdopterin synthase catalytic subunit,42761,3137,1.16 [1.10-1.22],5.231994614329466e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MOG,Myelin-oligodendrocyte glycoprotein,50668,3699,0.81 [0.74-0.88],2.139382997718497e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPHOSPH8,M-phase phosphoprotein 8,49323,3609,1.08 [1.04-1.12],0.0001313551119945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPI,Mannose-6-phosphate isomerase,50008,3649,1.08 [1.04-1.11],2.67475235393225e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPO,Myeloperoxidase,50252,3681,1.30 [1.23-1.38],7.616339480402141e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPRIP,Myosin phosphatase Rho-interacting protein,43438,3183,1.11 [1.03-1.20],0.0062659410619101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRC1,Macrophage mannose receptor 1,43751,3210,2.17 [1.94-2.42],9.887207100778557e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL24,"39S ribosomal protein L24, mitochondrial",42287,3106,1.13 [1.05-1.23],0.0023869421853793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL46,"39S ribosomal protein L46, mitochondrial",49082,3568,1.20 [1.09-1.33],0.0002427147816887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",43640,3195,1.08 [1.03-1.13],0.0006587360308579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSLN,Mesothelin,49928,3638,1.09 [1.04-1.15],0.0003771485594211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSR1,Macrophage scavenger receptor types I and II,50687,3698,1.86 [1.76-1.98],4.054246897016443e-93
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,50396,3675,1.07 [1.03-1.12],0.0004699748983321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSTN,Growth/differentiation factor 8,49323,3609,1.12 [1.06-1.19],3.074861082898293e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTDH,Protein LYRIC,42452,3109,1.14 [1.10-1.19],3.213134491762599e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,42925,3150,1.08 [1.05-1.11],5.143873697120131e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",43539,3194,1.06 [1.02-1.10],0.0022638269920377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTSS1,Protein MTSS 1,43539,3194,1.09 [1.06-1.12],3.1857056844994414e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTSS2,Protein MTSS 2,43518,3190,1.08 [1.05-1.12],5.481383461256171e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTUS1,Microtubule-associated tumor suppressor 1,42925,3150,1.43 [1.36-1.50],4.505737727565004e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC13,Mucin-13,49082,3568,2.13 [2.03-2.24],2.4050654254002805e-186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC2,Mucin-2,43726,3217,1.11 [1.08-1.15],1.637278437386397e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MVK,Mevalonate kinase,49283,3574,1.50 [1.45-1.55],3.400253552409287e-136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MXRA8,Matrix remodeling-associated protein 8,42761,3137,0.29 [0.26-0.32],6.334280985537852e-134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC1,"Myosin-binding protein C, slow-type",43722,3201,1.16 [1.11-1.22],1.4173440067711548e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC2,"Myosin-binding protein C, fast-type",42553,3118,1.07 [1.03-1.11],0.0002827931796413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,43640,3195,1.10 [1.05-1.16],8.386082806803663e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYDGF,Myeloid-derived growth factor,43722,3201,1.11 [1.07-1.15],9.648817206660348e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYH9,Myosin-9,43726,3217,1.08 [1.05-1.12],6.48093071264379e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL3,Myosin light chain 3,42553,3118,1.13 [1.08-1.18],1.0958156185169188e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL4,Myosin light chain 4,42553,3118,1.11 [1.05-1.18],0.0003114644798884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL6B,Myosin light chain 6B,42513,3125,0.95 [0.91-0.99],0.0091656167547811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",42513,3125,1.12 [1.05-1.19],0.0005029649046701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOC,Myocilin,50252,3681,0.79 [0.74-0.84],4.929538273547489e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MZB1,Marginal zone B- and B1-cell-specific protein,50369,3670,1.26 [1.19-1.33],9.104967603882336e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAA80,N-alpha-acetyltransferase 80,42513,3125,1.06 [1.03-1.09],9.018230992462052e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,49626,3633,0.90 [0.86-0.95],3.777066451151673e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NACC1,Nucleus accumbens-associated protein 1,43518,3190,1.15 [1.08-1.21],4.08798152422462e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NADK,NAD kinase,50238,3669,1.22 [1.16-1.28],2.4645308423584374e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGA,Alpha-N-acetylgalactosaminidase,42370,3098,1.12 [1.06-1.18],0.0001054755254567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,42761,3137,3.25 [2.80-3.77],5.222597007493547e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAMPT,Nicotinamide phosphoribosyltransferase,49060,3565,1.17 [1.12-1.23],1.9980444337155208e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",43640,3195,1.14 [1.06-1.23],0.0003691190046131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,50396,3675,1.53 [1.37-1.70],7.642889911176709e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBN,Nibrin,49283,3574,1.13 [1.08-1.19],4.914529290911157e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM1,Neural cell adhesion molecule 1,50445,3682,0.80 [0.73-0.88],3.3764519006141537e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM2,Neural cell adhesion molecule 2,50252,3681,0.75 [0.67-0.83],1.6879166247569612e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAN,Neurocan core protein,50687,3698,0.57 [0.53-0.62],1.050933920315946e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCF2,Neutrophil cytosol factor 2,50084,3658,1.10 [1.06-1.13],9.931093685483132e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCK2,Cytoplasmic protein NCK2,50453,3677,1.05 [1.02-1.07],0.0013158810309463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR1,Natural cytotoxicity triggering receptor 1,50097,3662,1.28 [1.19-1.39],2.1506448886954003e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,43539,3194,1.39 [1.26-1.53],1.3732194029432631e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCS1,Neuronal calcium sensor 1,50668,3699,1.61 [1.46-1.78],7.838615811301562e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,42380,3102,1.16 [1.05-1.27],0.002336216187082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",49060,3565,1.07 [1.03-1.11],0.0001528898887439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEB,Nebulin,42287,3106,1.12 [1.03-1.22],0.008158604969456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN2,Nectin-2,50163,3667,1.97 [1.80-2.16],5.3901330913000894e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN4,Nectin-4,50396,3675,1.14 [1.05-1.25],0.0031388028247369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,42452,3109,1.10 [1.03-1.19],0.0074932685596247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEFL,Neurofilament light polypeptide,48929,3558,1.26 [1.19-1.34],9.23997386611752e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL1,Protein kinase C-binding protein NELL1,50396,3675,0.77 [0.72-0.82],6.232977165561732e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL2,Protein kinase C-binding protein NELL2,50453,3677,1.30 [1.17-1.43],3.14511091957516e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEXN,Nexilin,43751,3210,1.08 [1.03-1.13],0.0027160789865083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFASC,Neurofascin,50792,3709,5.53 [5.07-6.03],0.0
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",50168,3665,1.06 [1.03-1.09],0.0001640587485049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",49283,3574,1.35 [1.29-1.41],3.0454190554225677e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFE2,Transcription factor NF-E2 45 kDa subunit,42553,3118,1.13 [1.08-1.19],9.460953071512829e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,42287,3106,1.11 [1.06-1.17],7.009516889014131e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKBIE,NF-kappa-B inhibitor epsilon,49060,3565,1.18 [1.11-1.25],4.0374164112075946e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",43539,3194,1.05 [1.02-1.09],0.0029208790585721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFX1,Transcriptional repressor NF-X1,42287,3106,1.14 [1.09-1.20],1.56587993129217e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGRN,Neugrin,43613,3190,1.45 [1.27-1.65],4.238785271897899e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NHLRC3,NHL repeat-containing protein 3,41729,3054,3.24 [2.90-3.62],1.0742325063664298e-96
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NID1,Nidogen-1,50281,3675,1.18 [1.09-1.27],1.8378431811076925e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NID2,Nidogen-2,50252,3681,1.08 [1.04-1.12],0.0001771669627725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NIT1,Deaminated glutathione amidase,42553,3118,1.13 [1.04-1.22],0.00247138858015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NIT2,Omega-amidase NIT2,43557,3186,1.25 [1.20-1.31],5.677853802868584e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME3,Nucleoside diphosphate kinase 3,50288,3666,0.58 [0.51-0.66],5.03049304023403e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,49859,3646,1.16 [1.12-1.20],4.87152929994183e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOMO1,Nodal modulator 1,50252,3681,2.40 [2.15-2.68],3.7225548761913446e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS1,"Nitric oxide synthase, brain",49082,3568,1.18 [1.12-1.24],1.016453373191501e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS3,"Nitric oxide synthase, endothelial",49082,3568,1.41 [1.35-1.47],6.99719949761572e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH1,Neurogenic locus notch homolog protein 1,50857,3718,1.87 [1.57-2.24],6.113515639561279e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH2,Neurogenic locus notch homolog protein 2,43726,3217,0.71 [0.62-0.82],4.825752744840048e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH3,Neurogenic locus notch homolog protein 3,50857,3718,0.58 [0.53-0.63],2.994993988727564e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPC2,NPC intracellular cholesterol transporter 2,42985,3167,1.84 [1.70-2.00],9.202223165223571e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPDC1,Neural proliferation differentiation and control protein 1,50238,3669,1.27 [1.17-1.39],4.419211533177423e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPL,N-acetylneuraminate lyase,43722,3201,1.54 [1.44-1.65],9.091743930641129e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPC,C-type natriuretic peptide,50168,3665,1.27 [1.20-1.34],2.226622121147048e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX1,Neuronal pentraxin-1,50252,3681,1.30 [1.21-1.39],1.167672508222171e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTXR,Neuronal pentraxin receptor,50238,3669,0.82 [0.75-0.89],4.75820627558625e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPY,Pro-neuropeptide Y,50668,3699,1.55 [1.48-1.63],6.320025832155472e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRCAM,Neuronal cell adhesion molecule,50238,3669,2.34 [2.15-2.55],2.44583550993628e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP1,Neuropilin-1,50528,3687,1.87 [1.69-2.07],6.66171732147374e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NSFL1C,NSFL1 cofactor p47,50687,3698,1.08 [1.04-1.13],0.0002913956205412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,43613,3190,1.50 [1.38-1.62],4.2705391583014156e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5E,5'-nucleotidase,50396,3675,1.34 [1.28-1.40],3.5510952552269566e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTF3,Neurotrophin-3,50168,3665,1.17 [1.08-1.27],9.686922440759226e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK2,BDNF/NT-3 growth factors receptor,50238,3669,1.54 [1.38-1.73],4.46306293819418e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK3,NT-3 growth factor receptor,50687,3698,0.39 [0.34-0.44],1.9940820723479863e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUB1,NEDD8 ultimate buster 1,50168,3665,1.05 [1.01-1.09],0.0074685374400257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUCB2,Nucleobindin-2,50586,3695,1.31 [1.21-1.41],4.163880769372328e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDC,Nuclear migration protein nudC,50792,3709,1.11 [1.06-1.16],9.355342550328703e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT16,U8 snoRNA-decapping enzyme,43465,3190,1.09 [1.05-1.13],8.25111994743473e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],50008,3649,0.93 [0.88-0.98],0.0068164030808138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT5,ADP-sugar pyrophosphatase,50252,3681,1.23 [1.16-1.30],2.8159118788585405e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUMB,Protein numb homolog,42452,3109,1.14 [1.09-1.19],1.876296437025274e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NXPH3,Neurexophilin-3,42452,3109,0.80 [0.72-0.90],0.0001487428088138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OBP2B,Odorant-binding protein 2b,49693,3637,0.82 [0.78-0.86],1.2428994171393264e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OCLN,Occludin,43640,3195,1.86 [1.74-1.98],2.2353658951493428e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ODAM,Odontogenic ameloblast-associated protein,48999,3563,0.90 [0.85-0.95],0.0001753328024646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGA,Protein O-GlcNAcase,43539,3194,1.09 [1.04-1.15],0.0002418966939619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGN,Mimecan,50252,3681,1.17 [1.09-1.25],7.854216636674697e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLFM4,Olfactomedin-4,41166,3014,1.19 [1.15-1.22],2.577406118657601e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLR1,Oxidized low-density lipoprotein receptor 1,49748,3638,1.19 [1.14-1.24],1.0094749923698673e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMD,Osteomodulin,50453,3677,0.59 [0.55-0.63],9.383708651392768e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMG,Oligodendrocyte-myelin glycoprotein,50008,3649,0.87 [0.84-0.91],3.7301688265242647e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPHN1,Oligophrenin-1,43613,3190,1.05 [1.01-1.08],0.0040829322105251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPLAH,5-oxoprolinase,42553,3118,1.14 [1.08-1.20],5.627015803186461e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPTC,Opticin,50008,3649,0.73 [0.68-0.78],6.034866165087287e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,50288,3666,1.33 [1.22-1.44],6.681474650963629e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSM,Oncostatin-M,49929,3649,1.33 [1.28-1.39],1.7071515189038813e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSMR,Oncostatin-M-specific receptor subunit beta,50528,3687,1.93 [1.68-2.22],8.364799939449949e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OTUD7B,OTU domain-containing protein 7B,43640,3195,1.15 [1.09-1.21],1.971812666427242e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXT,Oxytocin-neurophysin 1,50687,3698,1.19 [1.16-1.21],4.903436375113855e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,P4HB,Protein disulfide-isomerase,49998,3647,1.48 [1.38-1.60],1.9833748111388165e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PACS2,Phosphofurin acidic cluster sorting protein 2,42287,3106,1.10 [1.04-1.17],0.000443399749502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI2,Protein-arginine deiminase type-2,49283,3574,1.13 [1.08-1.18],3.247245894343334e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI4,Protein-arginine deiminase type-4,48999,3563,1.08 [1.04-1.12],6.209354359556554e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,49323,3609,1.38 [1.32-1.45],5.972762091944963e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,42553,3118,1.17 [1.09-1.26],2.675742578873772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAK4,Serine/threonine-protein kinase PAK 4,49082,3568,1.10 [1.05-1.15],5.029360746643961e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM2,Paralemmin-2,43613,3190,2.05 [1.91-2.20],3.0361101390298293e-90
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,50613,3703,0.84 [0.76-0.93],0.0012153797193202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAMR1,Inactive serine protease PAMR1,50252,3681,2.74 [2.46-3.04],7.931163601826682e-78
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARK7,Parkinson disease protein 7,50252,3681,1.10 [1.04-1.16],0.0013470495900444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARP1,Poly [ADP-ribose] polymerase 1,50168,3665,1.18 [1.13-1.23],4.426217958986442e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAXX,Protein PAXX,42761,3137,1.26 [1.17-1.35],5.010011660014932e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBLD,Phenazine biosynthesis-like domain-containing protein,49082,3568,1.43 [1.36-1.51],8.076211109880873e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,43539,3194,1.20 [1.08-1.33],0.0007789940104655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,42680,3132,1.92 [1.81-2.03],1.9816464805612962e-112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBP2,Poly(rC)-binding protein 2,43640,3195,1.08 [1.03-1.13],0.002245859554193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH1,Protocadherin-1,50628,3692,1.40 [1.23-1.58],2.273892997255329e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH12,Protocadherin-12,43640,3195,1.37 [1.20-1.56],1.9243360631251207e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH17,Protocadherin-17,50238,3669,1.89 [1.76-2.02],2.347343494401937e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH7,Protocadherin-7,43539,3194,1.15 [1.05-1.25],0.0027386936354752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH9,Protocadherin-9,43539,3194,1.65 [1.50-1.82],1.1909901467475713e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,43518,3190,1.17 [1.09-1.25],4.65146747306164e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,50857,3718,1.85 [1.72-1.98],6.839703117996582e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,43539,3194,1.19 [1.14-1.24],2.68289418577278e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,43722,3201,1.06 [1.02-1.10],0.0009619189902235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1,Programmed cell death protein 1,50585,3694,1.32 [1.24-1.40],7.575821369418186e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1LG2,Programmed cell death 1 ligand 2,50008,3649,1.53 [1.40-1.67],7.78408838688018e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD5,Programmed cell death protein 5,50687,3698,1.11 [1.06-1.17],3.114433666399316e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",42761,3137,1.06 [1.02-1.09],0.0009618218535929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFA,Platelet-derived growth factor subunit A,50857,3718,1.08 [1.04-1.12],0.0002390942125452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFB,Platelet-derived growth factor subunit B,50453,3677,1.08 [1.04-1.12],6.879672904027186e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFC,Platelet-derived growth factor C,49060,3565,1.33 [1.20-1.47],1.9693215368732026e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRA,Platelet-derived growth factor receptor alpha,50238,3669,1.42 [1.29-1.57],4.1531528185988095e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRB,Platelet-derived growth factor receptor beta,50857,3718,1.17 [1.07-1.27],0.0002512106061177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA3,Protein disulfide-isomerase A3,42761,3137,1.31 [1.16-1.48],1.8080032995949007e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA4,Protein disulfide-isomerase A4,43726,3217,1.11 [1.05-1.17],0.0002515772688856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDLIM7,PDZ and LIM domain protein 7,50453,3677,1.05 [1.02-1.07],9.323187033461104e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZD2,PDZ domain-containing protein 2,42287,3106,1.09 [1.03-1.15],0.0018726180121017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,42452,3109,1.97 [1.87-2.08],9.198002461856129e-132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEBP1,Phosphatidylethanolamine-binding protein 1,50252,3681,1.13 [1.08-1.19],1.0344150973605307e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PECAM1,Platelet endothelial cell adhesion molecule,50252,3681,1.40 [1.28-1.54],7.67447435917956e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEPD,Xaa-Pro dipeptidase,43751,3210,0.72 [0.64-0.82],8.111303719108815e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PER3,Period circadian protein homolog 3,42452,3109,1.04 [1.01-1.07],0.0040506113252737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PF4,Platelet factor 4,43459,3192,1.09 [1.05-1.13],2.117452565278256e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",49926,3645,1.08 [1.04-1.12],8.32101728697172e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGA4,Pepsin A-4,43751,3210,1.15 [1.10-1.20],1.098560753664395e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",43722,3201,1.13 [1.06-1.20],0.0001791913023589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGF,Placenta growth factor,50792,3709,1.95 [1.79-2.13],2.111693891391272e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGLYRP1,Peptidoglycan recognition protein 1,50610,3703,1.09 [1.02-1.17],0.0074053725336649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHACTR2,Phosphatase and actin regulator 2,43640,3195,1.05 [1.02-1.08],0.001848196465449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHLDB1,Pleckstrin homology-like domain family B member 1,43539,3194,1.16 [1.09-1.24],3.1135165397509213e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,49859,3646,1.28 [1.15-1.41],1.8976526359810643e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,42761,3137,1.39 [1.28-1.51],1.163842192675669e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI16,Peptidase inhibitor 16,43751,3210,0.75 [0.65-0.86],2.3795186627557936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI3,Elafin,49568,3627,1.16 [1.10-1.22],1.0218254369938304e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",43640,3195,1.11 [1.06-1.16],1.40361837754347e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIGR,Polymeric immunoglobulin receptor,49601,3630,2.69 [2.51-2.88],4.429506893426851e-171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,50168,3665,1.07 [1.02-1.12],0.0059631054010678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,50252,3681,1.63 [1.48-1.79],4.123077217268015e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,42452,3109,1.11 [1.04-1.17],0.0007986363183199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,50252,3681,1.62 [1.51-1.74],3.042907356891537e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,50238,3669,1.38 [1.31-1.46],5.689856713266329e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD1,Polycystin-1,43722,3201,2.26 [1.99-2.57],1.2743142990227506e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD2,Polycystin-2,42287,3106,1.17 [1.11-1.24],2.2950740780325256e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKN3,Serine/threonine-protein kinase N3,42925,3150,1.07 [1.02-1.12],0.004271711509404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G15,Phospholipase A2 group XV,50396,3675,2.82 [2.56-3.11],9.957926483433457e-94
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G1B,Phospholipase A2,50775,3714,0.65 [0.61-0.69],2.5234638092325488e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G4A,Cytosolic phospholipase A2,50453,3677,1.05 [1.02-1.08],0.0041558432102766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G7,Platelet-activating factor acetylhydrolase,50252,3681,0.51 [0.47-0.55],6.737468464865923e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAT,Tissue-type plasminogen activator,50690,3708,1.49 [1.41-1.58],1.1974486875016976e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAUR,Urokinase plasminogen activator surface receptor,49875,3640,2.31 [2.10-2.55],2.8905017871598384e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLB1,"Phospholipase B1, membrane-associated",43613,3190,0.88 [0.83-0.93],1.015529010724186e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",43613,3190,1.07 [1.03-1.10],0.0003068453452713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,43613,3190,1.18 [1.12-1.23],2.387757656431544e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLG,Plasminogen,42672,3127,1.56 [1.34-1.82],1.3876681511893402e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN1,Perilipin-1,49082,3568,1.40 [1.30-1.50],6.4530964131053945e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN3,Perilipin-3,50238,3669,1.23 [1.15-1.32],7.014460876987903e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLSCR3,Phospholipid scramblase 3,43531,3180,1.25 [1.18-1.32],3.3087387814933e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLTP,Phospholipid transfer protein,50694,3705,0.56 [0.52-0.61],7.076694560142892e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC2,Plexin domain-containing protein 2,43613,3190,1.54 [1.39-1.70],4.710210518712756e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNA4,Plexin-A4,50168,3665,1.10 [1.06-1.14],2.1294145528083802e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB2,Plexin-B2,50609,3699,6.12 [5.55-6.75],9.817674301534815e-293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB3,Plexin-B3,50075,3655,1.17 [1.10-1.24],4.10764535236317e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,49996,3654,1.02 [1.01-1.04],0.0049093058888717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMS1,PMS1 protein homolog 1,42513,3125,1.11 [1.04-1.18],0.0016055767800112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMVK,Phosphomevalonate kinase,49003,3566,1.04 [1.01-1.07],0.0028613873720409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIP,Pancreatic triacylglycerol lipase,43751,3210,1.11 [1.05-1.17],0.0001052600136734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,43613,3190,1.15 [1.11-1.20],1.025845299800014e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PODXL2,Podocalyxin-like protein 2,50396,3675,0.71 [0.64-0.78],3.329429192996475e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POF1B,Protein POF1B,42452,3109,1.40 [1.31-1.49],5.0161169824800165e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",50008,3649,1.30 [1.21-1.39],5.127613451258179e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON1,Serum paraoxonase/arylesterase 1,43751,3210,0.58 [0.52-0.64],2.9585159698519173e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON2,Serum paraoxonase/arylesterase 2,49323,3609,1.43 [1.32-1.55],2.544393517087084e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON3,Serum paraoxonase/lactonase 3,50453,3677,0.62 [0.59-0.64],3.1031208967712706e-140
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POSTN,Periostin,43726,3217,0.71 [0.65-0.78],7.169455434890401e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPBP,Platelet basic protein,43462,3190,1.09 [1.05-1.13],2.9088315180518047e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,50687,3698,1.14 [1.08-1.22],1.3703504209796711e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,50278,3674,1.04 [1.01-1.07],0.0094145727736014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPL,Periplakin,42452,3109,1.29 [1.17-1.42],2.6591416660783217e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,50396,3675,1.07 [1.04-1.10],5.513256805392981e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,42925,3150,1.07 [1.02-1.12],0.0029173586106032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,43640,3195,1.07 [1.02-1.11],0.0026533845709695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,43640,3195,1.22 [1.13-1.32],1.0307180058721205e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R2,Protein phosphatase inhibitor 2,50238,3669,1.08 [1.04-1.12],7.899155291946839e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R9B,Neurabin-2,50792,3709,1.10 [1.06-1.13],3.918299123226311e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,43539,3194,1.05 [1.02-1.07],0.0020187860494292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPY,Pancreatic prohormone,50167,3657,1.10 [1.07-1.13],9.700313102043951e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PQBP1,Polyglutamine-binding protein 1,49060,3565,1.09 [1.04-1.14],0.0003662470458797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRAP1,Proline-rich acidic protein 1,43726,3217,4.45 [4.06-4.88],1.8963552878911154e-219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRCP,Lysosomal Pro-X carboxypeptidase,50540,3698,3.08 [2.91-3.25],0.0
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",49283,3574,1.13 [1.08-1.17],3.741183529967918e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX6,Peroxiredoxin-6,50668,3699,0.86 [0.82-0.91],3.777218872085145e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PREB,Prolactin regulatory element-binding protein,49283,3574,1.35 [1.24-1.47],1.969003611696698e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRG3,Proteoglycan 3,43726,3217,0.86 [0.80-0.91],2.5545895939753185e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,49283,3574,1.10 [1.04-1.16],0.0008557933801718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,50238,3669,1.07 [1.03-1.11],0.0001615083456619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,43531,3184,1.15 [1.10-1.20],1.1853045645889267e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,49060,3565,1.19 [1.14-1.24],4.20092147544474e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROC,Vitamin K-dependent protein C,50363,3678,1.38 [1.23-1.55],2.6754373422876404e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROK1,Prokineticin-1,50168,3665,1.08 [1.03-1.14],0.0013057484557617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROS1,Vitamin K-dependent protein S,43788,3214,1.35 [1.18-1.53],7.190562037333676e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRRT3,Proline-rich transmembrane protein 3,42553,3118,0.77 [0.71-0.85],2.143348295628084e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS22,Brain-specific serine protease 4,42452,3109,1.20 [1.11-1.31],1.1415423541793971e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS27,Serine protease 27,50073,3660,1.24 [1.16-1.33],2.21293886241499e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS8,Prostasin,50039,3647,2.61 [2.45-2.78],9.009173727766233e-197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTG,Protogenin,50668,3699,1.51 [1.35-1.69],6.381814801294384e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTN3,Myeloblastin,48979,3585,1.15 [1.08-1.21],3.1944176529077084e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRUNE2,Protein prune homolog 2,42925,3150,1.50 [1.36-1.65],5.598556240271571e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAP,Prosaposin,43311,3190,1.70 [1.55-1.87],9.462615772328951e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAPL1,Proactivator polypeptide-like 1,43539,3194,0.74 [0.69-0.79],1.9375343787910065e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSIP1,PC4 and SFRS1-interacting protein,50168,3665,1.17 [1.12-1.21],2.8885049548353496e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMC3,26S proteasome regulatory subunit 6A,42155,3087,0.85 [0.75-0.95],0.0050128931120438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSME1,Proteasome activator complex subunit 1,49777,3644,1.27 [1.18-1.38],1.0626799460310039e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSME2,Proteasome activator complex subunit 2,49631,3628,1.28 [1.18-1.39],1.075147989024644e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMG3,Proteasome assembly chaperone 3,50168,3665,1.14 [1.08-1.20],4.347380210818139e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSPN,Persephin,50168,3665,1.04 [1.01-1.07],0.0094100532691979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSRC1,Proline/serine-rich coiled-coil protein 1,49060,3565,1.17 [1.12-1.22],2.0206974118988896e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGDS,Prostaglandin-H2 D-isomerase,49867,3637,1.59 [1.46-1.73],1.820132703396204e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGES2,Prostaglandin E synthase 2,42128,3082,1.19 [1.12-1.26],2.991662247305106e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGR1,Prostaglandin reductase 1,43722,3201,1.42 [1.37-1.48],2.0736489018946105e-78
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH,Parathyroid hormone,42513,3125,1.06 [1.02-1.11],0.0031800908150217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,50168,3665,1.26 [1.18-1.34],4.618108139672197e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTK7,Inactive tyrosine-protein kinase 7,49082,3568,1.32 [1.22-1.42],2.3281642977239367e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTN,Pleiotrophin,49323,3609,1.20 [1.13-1.27],3.9623037181708976e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,42452,3109,1.33 [1.25-1.40],1.6291813147553528e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,49859,3646,1.11 [1.07-1.15],2.9015694617355565e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,43722,3201,2.50 [2.26-2.76],1.894299068215249e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,43726,3217,1.99 [1.74-2.27],1.940649043360465e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,50857,3718,0.46 [0.42-0.51],9.882477477909213e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,43539,3194,1.32 [1.23-1.41],1.2307512245807436e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,43539,3194,1.70 [1.53-1.90],1.3909460335146725e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,50087,3657,1.78 [1.58-2.00],6.2212965714938885e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,43613,3190,0.79 [0.72-0.87],6.537032991694597e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,50857,3718,0.43 [0.38-0.48],2.9852391738098094e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,48850,3551,1.70 [1.63-1.78],4.010226548651837e-140
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTX3,Pentraxin-related protein PTX3,50168,3665,1.12 [1.05-1.19],0.0004472246002603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVR,Poliovirus receptor,50687,3698,1.79 [1.68-1.92],2.0345046764955736e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PXN,Paxillin,49082,3568,1.21 [1.14-1.27],2.025013623157278e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYDC1,Pyrin domain-containing protein 1,42553,3118,0.78 [0.71-0.86],9.905551779204109e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYY,Peptide YY,42287,3106,1.35 [1.31-1.40],1.432369638673075e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QDPR,Dihydropteridine reductase,49996,3654,1.39 [1.30-1.49],2.9928563836712016e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QPCT,Glutaminyl-peptide cyclotransferase,50289,3679,1.65 [1.48-1.83],7.994652403365434e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QSOX1,Sulfhydryl oxidase 1,42902,3139,1.35 [1.28-1.43],2.6009777182218267e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB11FIP3,Rab11 family-interacting protein 3,43722,3201,1.07 [1.03-1.10],4.632220155770465e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB27B,Ras-related protein Rab-27B,43722,3201,1.11 [1.07-1.16],7.195890169404763e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB39B,Ras-related protein Rab-39B,42287,3106,1.05 [1.01-1.08],0.0089898783214146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB44,Ras-related protein Rab-44,43518,3190,1.16 [1.09-1.24],2.073639095631124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6A,Ras-related protein Rab-6A,50168,3665,0.77 [0.72-0.82],1.6261566420374273e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RABEP1,Rab GTPase-binding effector protein 1,42761,3137,1.09 [1.04-1.14],9.744633175177745e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RABGAP1L,Rab GTPase-activating protein 1-like,49283,3574,1.08 [1.02-1.13],0.0031078287610608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RALY,RNA-binding protein Raly,43518,3190,1.19 [1.12-1.26],1.4826569740774794e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES1,Retinoic acid receptor responder protein 1,49060,3565,1.17 [1.08-1.27],0.0001012037462638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES2,Retinoic acid receptor responder protein 2,50528,3687,1.49 [1.42-1.57],8.399504849204267e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RASSF2,Ras association domain-containing protein 2,49060,3565,1.14 [1.09-1.20],6.420701989359348e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBFOX3,RNA binding protein fox-1 homolog 3,43640,3195,1.60 [1.50-1.71],9.65487277318705e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBKS,Ribokinase,49075,3598,1.33 [1.26-1.41],3.576796522120998e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP2,Retinol-binding protein 2,50008,3649,1.17 [1.13-1.21],2.0200752787572883e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP5,Retinol-binding protein 5,50008,3649,1.80 [1.73-1.88],9.692323497981597e-154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP7,Retinoid-binding protein 7,43539,3194,1.23 [1.17-1.29],6.113775434797077e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBPMS2,RNA-binding protein with multiple splicing 2,42553,3118,1.10 [1.06-1.13],4.783908891867231e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RCC1,Regulator of chromosome condensation,43518,3190,1.19 [1.12-1.26],3.4047502595070117e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RCOR1,REST corepressor 1,49323,3609,1.12 [1.05-1.19],0.0003301804960365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REEP4,Receptor expression-enhancing protein 4,43640,3195,1.10 [1.04-1.16],0.0003579060628346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1A,Lithostathine-1-alpha,49951,3650,1.47 [1.39-1.55],1.6417345712181216e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1B,Lithostathine-1-beta,50857,3718,1.32 [1.26-1.38],1.7881291261065798e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG3A,Regenerating islet-derived protein 3-alpha,50857,3718,1.13 [1.08-1.19],5.065152737855108e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG4,Regenerating islet-derived protein 4,50288,3666,1.74 [1.65-1.84],2.11392862251698e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RELT,Tumor necrosis factor receptor superfamily member 19L,50252,3681,1.33 [1.21-1.47],1.2132863247643204e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REN,Renin,50238,3669,1.50 [1.46-1.55],1.743615783413645e-158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,50008,3649,2.40 [2.23-2.59],2.9154142336548363e-119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RETN,Resistin,50119,3667,1.13 [1.06-1.21],0.0002197254605467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REXO2,"Oligoribonuclease, mitochondrial",42287,3106,0.89 [0.82-0.96],0.0039186842133844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RFC4,Replication factor C subunit 4,43518,3190,1.39 [1.21-1.61],6.1565061353420245e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGCC,Regulator of cell cycle RGCC,43640,3195,1.07 [1.02-1.12],0.0035503676641288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RHOC,Rho-related GTP-binding protein RhoC,49562,3633,1.04 [1.01-1.07],0.003629064277538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,42761,3137,1.74 [1.64-1.84],1.6083512032745498e-83
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RILP,Rab-interacting lysosomal protein,50521,3689,1.08 [1.03-1.13],0.0021769609252939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE1,Ribonuclease pancreatic,43751,3210,1.70 [1.51-1.90],1.1848363118561637e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE3,Eosinophil cationic protein,49996,3653,1.06 [1.04-1.09],1.2969677254629767e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE4,Ribonuclease 4,42300,3089,2.04 [1.84-2.25],1.0386899724554448e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE6,Ribonuclease K6,43441,3184,1.65 [1.53-1.77],4.190865266853711e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASEH2A,Ribonuclease H2 subunit A,43640,3195,1.10 [1.03-1.17],0.0072088725966947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASET2,Ribonuclease T2,50615,3705,1.99 [1.81-2.19],4.671195062129904e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF149,E3 ubiquitin-protein ligase RNF149,42553,3118,1.70 [1.54-1.87],1.8670407077209832e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF41,E3 ubiquitin-protein ligase NRDP1,49060,3565,1.12 [1.07-1.17],2.639007846232584e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO1,Roundabout homolog 1,50288,3666,2.63 [2.37-2.91],1.9834075474274532e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO2,Roundabout homolog 2,50687,3698,1.55 [1.37-1.75],1.743301669082311e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPE,Ribulose-phosphate 3-epimerase,42925,3150,1.07 [1.02-1.12],0.0060884953389246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPL14,60S ribosomal protein L14,42553,3118,1.24 [1.15-1.33],4.7240254911149854e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRAS,Ras-related protein R-Ras,42513,3125,1.04 [1.01-1.06],0.0066984464792587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,49060,3565,1.20 [1.14-1.26],1.4388150448702444e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,49060,3565,1.11 [1.06-1.15],8.20126358967792e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO1,R-spondin-1,49859,3646,0.85 [0.78-0.93],0.0001895445428991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO3,R-spondin-3,50668,3699,0.80 [0.72-0.88],1.9873161323860213e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",43640,3195,1.06 [1.02-1.09],0.0032891863262569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4R,Reticulon-4 receptor,50668,3699,2.49 [2.37-2.62],2.7178892522372484e-291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RWDD1,RWD domain-containing protein 1,50687,3698,1.09 [1.05-1.15],0.0001027185651846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A11,Protein S100-A11,49843,3630,1.15 [1.09-1.22],8.895471379489668e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A14,Protein S100-A14,43640,3195,0.81 [0.76-0.87],3.301288638585484e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A4,Protein S100-A4,50396,3675,1.10 [1.05-1.16],0.0002932034840833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100P,Protein S100-P,49323,3609,1.23 [1.18-1.29],4.7197640458222275e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,50168,3665,1.08 [1.04-1.12],0.000185776096248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SARG,Specifically androgen-regulated gene protein,43556,3193,1.09 [1.06-1.12],7.825128151212376e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,42287,3106,1.19 [1.11-1.29],2.923412506653957e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAT2,Thialysine N-epsilon-acetyltransferase,42925,3150,1.18 [1.12-1.23],6.03367815360368e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SBSN,Suprabasin,43645,3209,0.67 [0.61-0.74],2.3010929270783613e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCAMP3,Secretory carrier-associated membrane protein 3,50008,3649,1.15 [1.11-1.19],1.8905453537499016e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARA5,Scavenger receptor class A member 5,50687,3698,2.07 [1.89-2.27],1.5471600848003763e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB2,Lysosome membrane protein 2,48912,3581,1.72 [1.59-1.87],6.889298317302854e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF1,Scavenger receptor class F member 1,50857,3718,1.21 [1.13-1.30],1.4861264097232937e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF2,Scavenger receptor class F member 2,50687,3698,1.22 [1.10-1.34],0.0001173757853456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG2,Secretogranin-2,50439,3685,1.69 [1.55-1.84],3.1115141845620826e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG3,Secretogranin-3,50288,3666,0.80 [0.73-0.87],3.04258393498968e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB3A2,Secretoglobin family 3A member 2,50372,3673,0.93 [0.90-0.97],0.0001513230148094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGN,Secretagogin,49283,3574,1.33 [1.25-1.42],8.0177302467871e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCLY,Selenocysteine lyase,50521,3689,1.81 [1.71-1.91],2.8796870158958656e-101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,42393,3107,1.46 [1.37-1.56],2.0869385697572444e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRIB,Protein scribble homolog,42553,3118,1.09 [1.05-1.13],2.8901349598968808e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC1,Syndecan-1,50238,3669,1.42 [1.32-1.52],7.326603110398615e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDCCAG8,Serologically defined colon cancer antigen 8,43518,3190,1.07 [1.04-1.10],4.393816355831997e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDHB,Succinate dehydrogenase,43539,3194,1.09 [1.04-1.15],0.0003722438187848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDK2,Protein sidekick-2,42761,3137,1.20 [1.10-1.31],2.1526229586152603e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEC31A,Protein transport protein Sec31A,42553,3118,1.11 [1.06-1.16],6.410584706852286e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEL1L,Protein sel-1 homolog 1,42553,3118,1.45 [1.34-1.57],7.295587626310708e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELE,E-selectin,50857,3718,2.01 [1.90-2.13],1.5586910128744074e-124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELL,L-selectin,43788,3214,0.59 [0.51-0.68],5.274041861094557e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELP,P-selectin,50445,3682,1.21 [1.15-1.27],6.756284181499848e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELPLG,P-selectin glycoprotein ligand 1,50168,3665,2.38 [2.16-2.62],9.336241858182356e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3F,Semaphorin-3F,50238,3669,1.78 [1.60-1.99],3.477649500329761e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA6C,Semaphorin-6C,42452,3109,1.20 [1.06-1.36],0.0036802036889598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA7A,Semaphorin-7A,50690,3708,2.03 [1.88-2.19],2.140248977409624e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN3,Neuronal-specific septin-3,43640,3195,1.07 [1.03-1.12],0.001052168441857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN8,Septin-8,43531,3185,1.32 [1.20-1.46],2.0462148208293332e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA12,Serpin A12,48790,3578,1.10 [1.07-1.12],5.33463841104275e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA4,Kallistatin,42985,3140,2.06 [1.78-2.37],4.217362655301362e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA5,Plasma serine protease inhibitor,43151,3163,1.45 [1.33-1.58],1.758298228725367e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA7,Thyroxine-binding globulin,43788,3214,2.06 [1.73-2.45],3.061406549406904e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA9,Serpin A9,49768,3632,1.23 [1.18-1.28],1.3857627905545084e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB1,Leukocyte elastase inhibitor,50083,3665,1.05 [1.02-1.09],0.0023190346962717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB8,Serpin B8,50792,3709,1.14 [1.09-1.19],1.0336783002980254e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPIND1,Heparin cofactor 2,43706,3207,2.52 [2.24-2.83],1.959192797157266e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINE1,Plasminogen activator inhibitor 1,50857,3718,1.27 [1.22-1.33],2.9372872539097207e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINE2,Glia-derived nexin,43722,3201,1.11 [1.06-1.17],3.3897133265159085e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF1,Pigment epithelium-derived factor,43125,3165,3.00 [2.70-3.33],6.4536924080547876e-93
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF2,Alpha-2-antiplasmin,42962,3146,1.97 [1.54-2.53],7.329512102252362e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINH1,Serpin H1,42925,3150,1.08 [1.05-1.11],7.281491819056557e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI1,Neuroserpin,42684,3133,0.76 [0.67-0.85],4.645487924944927e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI2,Serpin I2,43539,3194,1.11 [1.05-1.18],0.0002011104667606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6L2,Seizure 6-like protein 2,50008,3649,0.83 [0.74-0.94],0.0033051202993671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP1,Secreted frizzled-related protein 1,49690,3634,1.23 [1.15-1.31],2.12944243935928e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP4,Secreted frizzled-related protein 4,42761,3137,1.48 [1.36-1.61],1.999244010394348e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPD,Pulmonary surfactant-associated protein D,50238,3669,1.11 [1.06-1.16],1.295833502984773e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SGSH,N-sulphoglucosamine sulphohydrolase,42983,3152,1.38 [1.31-1.46],9.443589737616471e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH2D1A,SH2 domain-containing protein 1A,50168,3665,1.14 [1.08-1.19],6.032426477857083e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3BP1,SH3 domain-binding protein 1,43539,3194,1.12 [1.05-1.20],0.000427510435369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3GLB2,Endophilin-B2,43613,3190,1.11 [1.06-1.16],4.093487472223715e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHBG,Sex hormone-binding globulin,43751,3210,0.51 [0.48-0.54],7.940510174685142e-116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHISA5,Protein shisa-5,43726,3217,1.72 [1.54-1.91],9.219807037823997e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",50372,3673,1.17 [1.13-1.21],2.7240859572533923e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIAE,Sialate O-acetylesterase,50311,3671,1.40 [1.31-1.48],2.5990942645394638e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC1,Sialoadhesin,50453,3677,1.64 [1.54-1.75],1.7039786773589605e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,50168,3665,1.75 [1.62-1.88],1.819989597319505e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,50252,3681,1.07 [1.04-1.09],1.4143970340570936e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,50668,3699,1.79 [1.65-1.94],5.612489832170242e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,50238,3669,2.99 [2.72-3.28],1.3775519582733766e-117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,42553,3118,1.63 [1.51-1.75],6.2284146591459885e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,50596,3696,1.63 [1.49-1.79],1.3101249023009084e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIL1,Nucleotide exchange factor SIL1,42553,3118,1.23 [1.12-1.34],6.638186215401876e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,50364,3674,1.14 [1.08-1.20],2.0160902500845945e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPB1,Signal-regulatory protein beta-1,50121,3650,1.40 [1.31-1.49],1.6770502761029207e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,50008,3649,1.06 [1.03-1.10],0.0006463292344192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,49283,3574,1.64 [1.56-1.73],3.0564550643145063e-80
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP1,Src kinase-associated phosphoprotein 1,49776,3638,1.24 [1.19-1.29],7.822115354989043e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP2,Src kinase-associated phosphoprotein 2,50453,3677,1.07 [1.04-1.10],5.011345455290105e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLA2,Src-like-adapter 2,43640,3195,1.06 [1.03-1.09],0.0004385250449239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF1,Signaling lymphocytic activation molecule,49283,3574,1.31 [1.25-1.38],1.1129048312655686e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF6,SLAM family member 6,49060,3565,1.38 [1.28-1.49],2.99426588264832e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF7,SLAM family member 7,50168,3665,1.18 [1.12-1.24],4.212943404678421e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF8,SLAM family member 8,49060,3565,1.47 [1.39-1.55],1.1724793302524808e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC16A1,Monocarboxylate transporter 1,49082,3568,1.16 [1.11-1.22],5.683610172959553e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC27A4,Long-chain fatty acid transport protein 4,49082,3568,1.14 [1.09-1.19],2.7389340629084563e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC28A1,Sodium/nucleoside cotransporter 1,42155,3087,1.10 [1.04-1.17],0.0004844377911209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC39A5,Zinc transporter ZIP5,50168,3665,1.11 [1.05-1.17],0.0001318679916627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,42761,3137,1.07 [1.03-1.12],0.0004704763078432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,43539,3194,1.23 [1.17-1.29],3.262548042069224e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLIT2,Slit homolog 2 protein,49082,3568,1.25 [1.19-1.32],1.4385454980799672e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK1,SLIT and NTRK-like protein 1,42452,3109,0.68 [0.61-0.76],1.5009166006261916e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK2,SLIT and NTRK-like protein 2,50668,3699,1.39 [1.29-1.49],3.750641991112769e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLMAP,Sarcolemmal membrane-associated protein,43539,3194,1.12 [1.08-1.16],1.85507949817314e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD1,Mothers against decapentaplegic homolog 1,49060,3565,1.12 [1.08-1.16],1.1404588027830446e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD2,Mothers against decapentaplegic homolog 2,43518,3190,1.10 [1.05-1.16],5.562158726386271e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,43539,3194,1.17 [1.12-1.23],1.1291450692032636e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC1,SPARC-related modular calcium-binding protein 1,50668,3699,1.82 [1.68-1.97],1.6490015009924234e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC2,SPARC-related modular calcium-binding protein 2,50453,3677,1.32 [1.22-1.41],7.285717423474035e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD1,Sphingomyelin phosphodiesterase,50438,3675,1.39 [1.32-1.47],1.5049902462560073e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMTN,Smoothelin,43529,3184,1.09 [1.05-1.13],1.2453897774444431e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP23,Synaptosomal-associated protein 23,50238,3669,1.10 [1.06-1.13],1.6712867199654169e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP29,Synaptosomal-associated protein 29,50396,3675,1.09 [1.06-1.13],3.4161483363260524e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCA,Alpha-synuclein,42761,3137,1.08 [1.05-1.11],7.098939924275797e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCG,Gamma-synuclein,49859,3646,1.24 [1.19-1.30],4.249284529419943e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",42553,3118,1.31 [1.19-1.44],2.880560282916676e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',43613,3190,1.25 [1.18-1.32],7.89705210949893e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX15,Sorting nexin-15,42761,3137,1.11 [1.05-1.18],0.0007011699612578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX2,Sorting nexin-2,43518,3190,1.07 [1.03-1.11],0.0009893793431738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX9,Sorting nexin-9,50238,3669,1.08 [1.04-1.13],0.0003582658489448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD1,Superoxide dismutase [Cu-Zn],49227,3591,1.12 [1.05-1.19],0.0002913852369329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",50252,3681,1.29 [1.20-1.38],6.887140702446226e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD3,Extracellular superoxide dismutase,43751,3210,0.87 [0.81-0.93],2.142593192514544e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORBS1,Sorbin and SH3 domain-containing protein 1,43640,3195,1.24 [1.16-1.33],5.65639373157766e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORCS2,VPS10 domain-containing receptor SorCS2,49060,3565,1.30 [1.20-1.41],2.608985434033586e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORD,Sorbitol dehydrogenase,50439,3681,1.48 [1.41-1.54],1.6938987941239997e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORT1,Sortilin,50163,3667,1.48 [1.38-1.60],7.035734225858706e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOST,Sclerostin,50163,3667,1.34 [1.24-1.44],1.283004578049198e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPAG1,Sperm-associated antigen 1,43640,3195,1.11 [1.06-1.18],7.803903330568554e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPARC,SPARC,50396,3675,1.09 [1.04-1.13],0.0001233274437387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPARCL1,SPARC-like protein 1,50285,3667,0.67 [0.60-0.74],2.9002957075625653e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPART,Spartin,42761,3137,1.08 [1.03-1.12],0.001231709220276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK1,Serine protease inhibitor Kazal-type 1,50252,3681,1.59 [1.50-1.68],6.425664430684828e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK2,Serine protease inhibitor Kazal-type 2,42761,3137,0.87 [0.80-0.95],0.0021960781181968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK4,Serine protease inhibitor Kazal-type 4,50168,3665,1.45 [1.39-1.51],6.802347716814817e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK5,Serine protease inhibitor Kazal-type 5,50252,3681,0.83 [0.76-0.91],2.1192270786079804e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK6,Serine protease inhibitor Kazal-type 6,50668,3699,1.10 [1.04-1.16],0.0011204619072621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT1,Kunitz-type protease inhibitor 1,50085,3668,1.89 [1.71-2.09],9.137686787806444e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT2,Kunitz-type protease inhibitor 2,50453,3677,1.39 [1.30-1.50],4.642428090968288e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT3,Kunitz-type protease inhibitor 3,43539,3194,0.96 [0.94-0.99],0.0009191508653502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPOCK1,Testican-1,49859,3646,0.82 [0.73-0.92],0.0005708383895157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON1,Spondin-1,50288,3666,1.67 [1.55-1.80],7.30752698488103e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON2,Spondin-2,49996,3653,1.98 [1.82-2.14],1.1630482790908409e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPTLC1,Serine palmitoyltransferase 1,43613,3190,1.13 [1.04-1.23],0.0028833405641334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRC,Proto-oncogene tyrosine-protein kinase Src,50317,3672,1.04 [1.01-1.06],0.005392147096742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRP14,Signal recognition particle 14 kDa protein,50008,3649,1.23 [1.17-1.28],3.979968295174173e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPK2,SRSF protein kinase 2,50168,3665,1.10 [1.06-1.14],2.3285271324149943e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPX,Sushi repeat-containing protein SRPX,43722,3201,1.20 [1.09-1.32],0.0001360886210065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,50163,3667,1.18 [1.15-1.21],1.1958894115939673e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,50445,3682,1.95 [1.83-2.09],9.697531358656594e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,43539,3194,1.18 [1.11-1.26],9.352758957761205e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST13,Hsc70-interacting protein,42761,3137,1.11 [1.04-1.18],0.0008692892552161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",50008,3649,0.85 [0.79-0.91],7.305587776936558e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",50857,3718,1.75 [1.61-1.91],5.254591478905161e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAB2,Stabilin-2,43726,3217,2.36 [2.11-2.64],2.860384388493186e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAMBP,STAM-binding protein,49776,3638,1.07 [1.03-1.12],0.0025085516983034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAT2,Signal transducer and activator of transcription 2,42452,3109,1.10 [1.05-1.15],3.2296495904736184e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAT5B,Signal transducer and activator of transcription 5B,50008,3649,1.03 [1.01-1.06],0.0022786189228656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC1,Stanniocalcin-1,50687,3698,1.54 [1.46-1.64],5.981563269613044e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC2,Stanniocalcin-2,50188,3678,1.35 [1.20-1.52],6.168167830129702e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STIP1,Stress-induced-phosphoprotein 1,50167,3671,1.10 [1.05-1.15],2.837671196299339e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK11,Serine/threonine-protein kinase STK11,49323,3609,1.09 [1.05-1.14],1.2192811211838486e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK24,Serine/threonine-protein kinase 24,49082,3568,1.09 [1.04-1.15],0.0002662925290507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK4,Serine/threonine-protein kinase 4,50238,3669,1.06 [1.02-1.09],0.0014062961006091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX16,Syntaxin-16,49060,3565,1.13 [1.08-1.19],6.298956619296183e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX4,Syntaxin-4,50008,3649,1.17 [1.12-1.22],1.6182107990928913e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX6,Syntaxin-6,49060,3565,1.09 [1.04-1.14],0.0001170436884245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX7,Syntaxin-7,42452,3109,1.18 [1.10-1.26],7.4711070127133025e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX8,Syntaxin-8,50168,3665,1.16 [1.10-1.23],6.027011506228202e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUGP1,SURP and G-patch domain-containing protein 1,43539,3194,1.16 [1.07-1.26],0.0001983310365398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT2A1,Bile salt sulfotransferase,50168,3665,1.47 [1.42-1.53],1.2864723404425683e-93
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,50687,3698,1.31 [1.24-1.39],1.6761640052717598e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUOX,"Sulfite oxidase, mitochondrial",43640,3195,1.45 [1.38-1.52],3.9412440912555124e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD1,Sushi domain-containing protein 1,49323,3609,1.10 [1.04-1.17],0.0021126968139845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD2,Sushi domain-containing protein 2,50252,3681,1.28 [1.16-1.41],5.798679760572133e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD4,Sushi domain-containing protein 4,43518,3190,1.13 [1.05-1.23],0.0014681946798725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD5,Sushi domain-containing protein 5,42524,3122,0.58 [0.53-0.64],2.322110430804486e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SV2A,Synaptic vesicle glycoprotein 2A,42513,3125,1.11 [1.05-1.17],8.523219054941674e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYAP1,Synapse-associated protein 1,42761,3137,1.09 [1.03-1.15],0.0048955156443949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYT1,Synaptotagmin-1,43613,3190,0.85 [0.77-0.93],0.0006215885915854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYTL4,Synaptotagmin-like protein 4,43722,3201,1.11 [1.06-1.16],5.04225104227161e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TADA3,Transcriptional adapter 3,43518,3190,1.20 [1.10-1.30],1.994252376249891e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAFA5,Chemokine-like protein TAFA-5,50008,3649,1.13 [1.04-1.22],0.0027502756144192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TALDO1,Transaldolase,43560,3208,1.43 [1.33-1.53],4.926630345861185e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TANK,TRAF family member-associated NF-kappa-B activator,49283,3574,1.12 [1.07-1.17],1.707456412502378e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARBP2,RISC-loading complex subunit TARBP2,49082,3568,1.10 [1.06-1.14],1.28417928263883e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",43518,3190,1.18 [1.08-1.29],0.000323167306882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAX1BP1,Tax1-binding protein 1,43613,3190,1.20 [1.14-1.26],3.7665439461713506e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D17,TBC1 domain family member 17,49082,3568,1.11 [1.04-1.18],0.001667640620622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D23,TBC1 domain family member 23,50008,3649,1.06 [1.03-1.10],0.0001557335403967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D5,TBC1 domain family member 5,50168,3665,1.08 [1.04-1.11],7.82347106990767e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCA,Tubulin-specific chaperone A,42761,3137,1.07 [1.02-1.11],0.0019726732513381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCB,Tubulin-folding cofactor B,49859,3646,1.04 [1.01-1.07],0.0070862467870315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCC,Tubulin-specific chaperone C,49859,3646,1.06 [1.02-1.10],0.0019604627077254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN1,Transcobalamin-1,42874,3132,1.18 [1.08-1.30],0.0002690395429451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN2,Transcobalamin-2,50777,3713,1.71 [1.57-1.86],3.7857169448483874e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCOF1,Treacle protein,43722,3201,1.61 [1.48-1.74],1.2207748173740476e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCTN3,Tectonic-3,43722,3201,1.96 [1.76-2.19],8.204029795988085e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDGF1,Teratocarcinoma-derived growth factor 1,49082,3568,1.04 [1.02-1.06],0.0003665913307293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDO2,"Tryptophan 2,3-dioxygenase",42513,3125,1.16 [1.07-1.25],0.0002812643181521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,43518,3190,1.09 [1.04-1.14],0.0001808570427365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDRKH,Tudor and KH domain-containing protein,49082,3568,1.12 [1.08-1.16],7.023246725359761e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEK,Angiopoietin-1 receptor,50396,3675,2.69 [2.37-3.06],3.169697798902337e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TF,Serotransferrin,43788,3214,1.95 [1.67-2.27],1.6428863578111416e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF1,Trefoil factor 1,50005,3664,1.26 [1.22-1.30],7.538253625873614e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF2,Trefoil factor 2,50372,3673,1.51 [1.44-1.58],2.6105267749295603e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF3,Trefoil factor 3,50203,3657,1.44 [1.37-1.52],2.7925191749531875e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI2,Tissue factor pathway inhibitor 2,50241,3667,1.29 [1.21-1.36],3.8186641820812077e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFRC,Transferrin receptor protein 1,50446,3682,1.15 [1.07-1.24],0.0001624132751955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TG,Thyroglobulin,43518,3190,0.92 [0.89-0.95],4.888430562448629e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFA,Protransforming growth factor alpha,50168,3665,1.58 [1.49-1.67],1.3165528275742902e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB1,Transforming growth factor beta-1 proprotein,50709,3703,1.57 [1.47-1.68],5.4711202001601355e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,49951,3651,1.36 [1.22-1.51],1.0008728539691997e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR2,TGF-beta receptor type-2,50396,3675,1.42 [1.31-1.54],7.680616196038465e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR3,Transforming growth factor beta receptor type 3,50857,3718,0.70 [0.64-0.76],2.7482016490596883e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBD,Thrombomodulin,50238,3669,1.25 [1.13-1.38],1.2785823749158477e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS2,Thrombospondin-2,50252,3681,2.17 [2.05-2.30],2.4829709791039563e-148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS4,Thrombospondin-4,50281,3675,1.35 [1.27-1.44],1.5660428627852634e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THOP1,Thimet oligopeptidase,50000,3657,1.71 [1.57-1.86],3.1063520128992035e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THPO,Thrombopoietin,49323,3609,0.86 [0.80-0.93],0.0001406610296131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THY1,Thy-1 membrane glycoprotein,50687,3698,1.35 [1.22-1.49],3.1937006697993803e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIA1,Nucleolysin TIA-1 isoform p40,48766,3563,1.04 [1.01-1.07],0.0016374106901443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIE1,Tyrosine-protein kinase receptor Tie-1,50857,3718,1.21 [1.12-1.31],5.876021485368072e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",48999,3560,1.18 [1.11-1.26],9.451730848609834e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,42925,3150,1.21 [1.12-1.32],6.4873451394490326e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,43722,3201,1.16 [1.07-1.26],0.0004025329900621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,43613,3190,1.06 [1.02-1.10],0.0066854768412315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP1,Metalloproteinase inhibitor 1,49705,3622,2.14 [1.95-2.33],6.420277300894668e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP3,Metalloproteinase inhibitor 3,50453,3677,1.09 [1.07-1.12],3.364026860970617e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP4,Metalloproteinase inhibitor 4,50252,3681,0.67 [0.62-0.73],1.6617438503444296e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TJAP1,Tight junction-associated protein 1,50396,3675,1.07 [1.04-1.11],7.799599462794353e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TK1,"Thymidine kinase, cytosolic",42925,3150,1.13 [1.06-1.22],0.0005085493602324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR1,Toll-like receptor 1,42452,3109,1.46 [1.30-1.65],8.262095354782032e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR2,Toll-like receptor 2,42925,3150,1.24 [1.07-1.43],0.0044268626073603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR3,Toll-like receptor 3,50792,3709,1.34 [1.28-1.41],4.668278819507924e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED8,Protein TMED8,43539,3194,1.05 [1.01-1.08],0.0070310107660352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS15,Enteropeptidase,50008,3649,1.33 [1.29-1.37],6.067540926084492e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS5,Transmembrane protease serine 5,49615,3628,0.85 [0.79-0.91],1.5228961039417404e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMSB10,Thymosin beta-10,50252,3681,1.11 [1.07-1.16],6.82658465088451e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNC,Tenascin,50445,3682,0.84 [0.79-0.89],4.652323160075608e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNF,Tumor necrosis factor,49246,3605,1.38 [1.31-1.47],5.1200173387496475e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,49859,3646,2.08 [1.96-2.20],3.3527187659809914e-136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,49859,3646,1.37 [1.32-1.41],1.4934716917289348e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,50363,3684,1.17 [1.10-1.24],8.790841231739339e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,50792,3709,2.11 [1.98-2.26],3.531166243131333e-111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,50204,3657,2.27 [2.08-2.47],6.956342963226075e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,50396,3675,1.95 [1.81-2.10],1.0037033875565324e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,50288,3666,1.26 [1.17-1.37],8.927519621128899e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,49283,3574,1.13 [1.06-1.21],0.0003180208767885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,50288,3666,1.78 [1.63-1.94],4.274847106237348e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,42761,3137,0.89 [0.82-0.97],0.0095693570637164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,50252,3681,2.15 [1.98-2.34],1.8412546852311643e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,50252,3681,1.50 [1.42-1.58],3.8072500026905937e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,50687,3698,1.14 [1.03-1.27],0.0098358740531981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,50709,3703,1.54 [1.44-1.65],9.370662020982596e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,49859,3646,1.35 [1.29-1.41],7.681874647963127e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,49859,3646,1.39 [1.30-1.47],7.848874047693367e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,50792,3709,0.55 [0.49-0.62],3.0453089758257553e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,50168,3665,0.80 [0.76-0.84],7.662795756208922e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,50792,3709,0.50 [0.45-0.55],2.72149769961486e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,50453,3677,1.65 [1.49-1.84],1.3790628648749093e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,50773,3714,1.63 [1.48-1.79],1.1392158421025382e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,49859,3646,1.26 [1.20-1.33],1.3295435465398351e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,43726,3217,1.54 [1.41-1.68],2.9597491388394262e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNIP1,TNFAIP3-interacting protein 1,43613,3190,1.11 [1.07-1.15],1.858278838123031e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNN,Tenascin-N,43726,3217,1.47 [1.36-1.58],1.35945167377192e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNXB,Tenascin-X,50252,3681,0.75 [0.67-0.83],2.320907653664543e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,43722,3201,1.16 [1.11-1.21],4.395757619841136e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP1,DNA topoisomerase 1,43539,3194,1.08 [1.05-1.11],5.063261786152669e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP2B,DNA topoisomerase 2-beta,42452,3109,1.16 [1.11-1.21],4.196853928939456e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOR1AIP1,Torsin-1A-interacting protein 1,42553,3118,1.17 [1.10-1.24],1.679127863280669e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53,Cellular tumor antigen p53,49060,3565,1.16 [1.09-1.24],1.3425090923286108e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53I3,Quinone oxidoreductase PIG3,41833,3056,1.39 [1.31-1.48],1.3266933595780047e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPD52L2,Tumor protein D54,42761,3137,1.05 [1.02-1.09],0.0010829480245329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPK1,Thiamin pyrophosphokinase 1,43722,3201,0.59 [0.52-0.67],5.2684651694351926e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPP1,Tripeptidyl-peptidase 1,49870,3634,1.54 [1.46-1.63],8.630271753159434e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPPP3,Tubulin polymerization-promoting protein family member 3,49082,3568,0.88 [0.81-0.96],0.0025891919692123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPR,Nucleoprotein TPR,42287,3106,1.23 [1.16-1.30],2.1020310808139775e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSAB1,Tryptase alpha/beta-1,50708,3702,1.15 [1.08-1.21],2.460054297936188e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRAF2,TNF receptor-associated factor 2,50168,3665,1.06 [1.02-1.10],0.0073792273672121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",42452,3109,1.12 [1.03-1.22],0.0096098151769161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREH,Trehalase,43726,3217,1.52 [1.45-1.59],4.3113009066660514e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREM2,Triggering receptor expressed on myeloid cells 2,50204,3657,1.47 [1.40-1.55],3.974425499380876e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,50668,3699,1.13 [1.08-1.18],1.358180605603415e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,50168,3665,1.06 [1.02-1.10],0.0040274778831087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM24,Transcription intermediary factor 1-alpha,42844,3143,1.13 [1.08-1.19],1.0997278004797924e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,43539,3194,1.06 [1.03-1.09],0.0004007452172686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM5,Tripartite motif-containing protein 5,50168,3665,1.07 [1.03-1.11],8.652709218519346e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,43518,3190,1.09 [1.04-1.13],3.1505497900868935e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSC22D1,TSC22 domain family protein 1,43640,3195,1.08 [1.03-1.13],0.0032114971367847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN1,Tetraspanin-1,49323,3609,1.08 [1.03-1.12],0.0004378075229962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN7,Tetraspanin-7,42308,3098,0.95 [0.91-0.99],0.0098969134875571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN8,Tetraspanin-8,43539,3194,1.07 [1.03-1.10],0.0002354390014585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TWF2,Twinfilin-2,43726,3217,1.06 [1.02-1.10],0.0035006398845701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXLNA,Alpha-taxilin,49859,3646,1.13 [1.09-1.17],8.161373476235906e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC15,Thioredoxin domain-containing protein 15,50396,3675,1.23 [1.11-1.37],9.194147422075028e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC5,Thioredoxin domain-containing protein 5,50687,3698,1.15 [1.10-1.20],6.405429682718847e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC9,Thioredoxin domain-containing protein 9,43613,3190,1.10 [1.03-1.17],0.0024786060272543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",50252,3681,1.35 [1.27-1.44],2.0030981285510703e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYMP,Thymidine phosphorylase,49916,3639,1.15 [1.10-1.20],5.30866693306829e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",42452,3109,1.16 [1.10-1.23],1.3187626832473486e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,43722,3201,1.13 [1.07-1.19],1.1736504067298968e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBQLN3,Ubiquilin-3,42287,3106,1.08 [1.02-1.15],0.0099057036940359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBXN1,UBX domain-containing protein 1,42761,3137,1.08 [1.03-1.13],0.0030397034842196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,43539,3194,1.04 [1.02-1.07],0.0003703723471466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ULBP2,UL16-binding protein 2,49859,3646,1.61 [1.50-1.73],3.6074761867800695e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UMOD,Uromodulin,50700,3704,0.69 [0.65-0.72],9.593926063997022e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UNC79,Protein unc-79 homolog,42155,3087,1.10 [1.04-1.17],0.0017085670579573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPB1,Beta-ureidopropionase,43722,3201,1.51 [1.47-1.56],1.135263878047629e-160
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UROD,Uroporphyrinogen decarboxylase,42761,3137,1.13 [1.07-1.18],1.8262311071981943e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USO1,General vesicular transport factor p115,50008,3649,1.08 [1.05-1.12],4.516259542537781e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,43518,3190,1.12 [1.06-1.17],4.160684202314724e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,43613,3190,1.16 [1.07-1.26],0.000438903776074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,49323,3609,1.07 [1.04-1.11],4.488936268637775e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UXS1,UDP-glucuronic acid decarboxylase 1,49060,3565,1.10 [1.04-1.16],0.0005196815303343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAMP5,Vesicle-associated membrane protein 5,49323,3609,1.14 [1.09-1.20],1.00392401878955e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAMP8,Vesicle-associated membrane protein 8,42452,3109,1.09 [1.05-1.13],1.1292142912661246e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,50168,3665,1.07 [1.03-1.10],0.0003280231459792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,50008,3649,0.45 [0.39-0.53],8.1093824826077105e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAM1,Vascular cell adhesion protein 1,50363,3678,1.65 [1.49-1.83],1.934468914236276e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAN,Versican core protein,50687,3698,0.77 [0.69-0.84],7.83314075663465e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFA,Vascular endothelial growth factor A,50628,3695,1.27 [1.21-1.33],1.305773542627563e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFC,Vascular endothelial growth factor C,50396,3675,1.13 [1.07-1.19],3.272069160816106e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VGF,Neurosecretory protein VGF,43640,3195,0.77 [0.69-0.86],3.561373460406716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VMO1,Vitelline membrane outer layer protein 1 homolog,50008,3649,1.38 [1.32-1.45],3.123440305684233e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN1,Pantetheinase,43751,3210,1.44 [1.37-1.51],1.0239781804909931e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN2,Vascular non-inflammatory molecule 2,50008,3649,1.35 [1.26-1.44],6.902831798449296e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS37A,Vacuolar protein sorting-associated protein 37A,50008,3649,1.11 [1.07-1.15],1.2260572043197682e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,50008,3649,1.09 [1.05-1.13],4.1740213704411225e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,43518,3190,1.25 [1.14-1.36],6.207635124850886e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,43518,3190,1.52 [1.45-1.59],1.92648545783472e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,50188,3678,1.66 [1.55-1.77],8.73946916966225e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,50161,3662,1.14 [1.09-1.20],3.639403092005966e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSNL1,Visinin-like protein 1,43613,3190,1.45 [1.35-1.56],5.4704690267951724e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM1,V-set and transmembrane domain-containing protein 1,49082,3568,1.09 [1.03-1.16],0.0031731183279434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,49323,3609,1.25 [1.20-1.31],6.06049315658449e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,49060,3565,1.20 [1.09-1.31],9.377102273280448e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,42761,3137,1.17 [1.11-1.24],7.66021301385681e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWA1,von Willebrand factor A domain-containing protein 1,50593,3692,1.47 [1.37-1.57],4.346072171254283e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2,Brorin,49691,3632,1.17 [1.09-1.26],2.0666096848779927e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,43640,3195,0.76 [0.69-0.83],1.1063068784031275e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWF,von Willebrand factor,50857,3718,1.10 [1.05-1.14],5.090368826806948e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",50252,3681,1.27 [1.17-1.37],1.619906245335805e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,49323,3609,1.07 [1.04-1.10],3.40507426793479e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASHC3,WASH complex subunit 3,43613,3190,1.12 [1.07-1.17],3.491236645535621e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WDR46,WD repeat-containing protein 46,43518,3190,1.15 [1.06-1.25],0.0010086595292011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC1,WAP four-disulfide core domain protein 1,42640,3128,1.14 [1.08-1.20],4.707604789695787e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC2,WAP four-disulfide core domain protein 2,47688,3482,1.49 [1.39-1.60],1.4459023261403545e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",49693,3633,0.89 [0.83-0.96],0.002296638497719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",50288,3666,0.64 [0.59-0.70],3.2613848386847405e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WIF1,Wnt inhibitory factor 1,50668,3699,0.58 [0.53-0.63],5.6667008483356685e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,49859,3646,1.17 [1.11-1.24],1.3463848266664041e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XCL1,Lymphotactin,50668,3699,1.22 [1.16-1.28],3.567841017309427e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XIAP,E3 ubiquitin-protein ligase XIAP,42452,3109,1.14 [1.08-1.21],7.315141808474272e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XPNPEP2,Xaa-Pro aminopeptidase 2,50396,3675,0.94 [0.91-0.96],7.884048049746639e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XRCC4,DNA repair protein XRCC4,49082,3568,1.19 [1.10-1.28],1.096278802018738e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YAP1,Transcriptional coactivator YAP1,43613,3190,1.57 [1.40-1.76],8.739907575912916e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",43539,3194,1.06 [1.03-1.08],1.482833109782716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YES1,Tyrosine-protein kinase Yes,50008,3649,1.08 [1.05-1.11],1.2692646416614394e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YOD1,Ubiquitin thioesterase OTU1,42287,3106,1.10 [1.04-1.16],0.0005060905734149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YTHDF3,YTH domain-containing family protein 3,49283,3574,1.09 [1.06-1.13],3.7784927511792057e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YWHAQ,14-3-3 protein theta,42761,3137,1.08 [1.03-1.13],0.0008737090274856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,49060,3565,1.11 [1.07-1.16],3.691484962685484e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,49323,3609,1.24 [1.17-1.31],1.87986464723286e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZHX2,Zinc fingers and homeoboxes protein 2,43613,3190,1.33 [1.23-1.44],6.380778888268358e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRD2,Protein ZNRD2,43539,3194,1.21 [1.16-1.27],1.810915790722721e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,43518,3190,1.09 [1.02-1.16],0.0080159347122544
